Rhian Touyz

Q: What Schools Are Affiliated With Rhian Touyz

Rhian Touyz is affiliated with the following schools: University of Glasgow, University of the Witwatersrand, Paris Diderot University, Monash University, University of Calgary, McGill University, Université de Montréal, Sun Yat-sen University, University of Cape Town, University College London, University of Ottawa, Tel Aviv University

Rhian Touyz's AcademicInfluence.com Rankings

Rhian Touyz

Law

#1119

World Rank

#1432

Historical Rank

Common Law

#14

World Rank

#16

Historical Rank

law Degrees

Download Badge

Rhian Touyz's Degrees

Bachelors Medicine University of Cape Town
PhD Medicine University of Cape Town

Why Is Rhian Touyz Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Rhian M. Touyz Koppel MBBCh, MSc , PhD, FRCP, FRSE, FMedSci, FCAHS is a Canadian medical researcher. She is currently serving as the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre in Montreal, Canada, since 2021. A clinician scientist, her research primarily focuses on hypertension and cardiovascular disease.

(See a Problem?)

Rhian Touyz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options (2020) (1029)
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 (2020) (965)
Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. (2000) (942)
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. (2014) (923)
Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? (2004) (842)
Clinical Practice Guidelines for the Management of Hypertension in the Community (2014) (726)
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms (2017) (721)
NADPH Oxidases, Reactive Oxygen Species, and Hypertension (2008) (636)
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019) (630)
Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. (2000) (621)
Reactive oxygen species in vascular biology: implications in hypertension (2004) (617)
Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II (2002) (607)
Redox signaling in hypertension. (2006) (571)
Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent Pathways (2007) (483)
Antioxidant Effects of Vitamins C and E Are Associated With Altered Activation of Vascular NADPH Oxidase and Superoxide Dismutase in Stroke-Prone SHR (2001) (414)
Reactive oxygen species and vascular biology: implications in human hypertension (2011) (398)
Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress (2002) (393)
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. (2010) (390)
Oxidative Stress, Inflammation, and Vascular Aging in Hypertension (2017) (365)
Vascular dysfunction—The disregarded partner of Alzheimer's disease (2019) (361)
Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. (2013) (352)
Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. (2010) (351)
Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. (2018) (341)
NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. (2013) (331)
Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction (2004) (323)
Oxidative Stress and Hypertension: Current Concepts (2010) (317)
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis (2013) (313)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (2020) (310)
Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease. (2004) (309)
Microparticles: biomarkers and beyond. (2013) (308)
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. (2006) (306)
Vascular smooth muscle contraction in hypertension (2018) (298)
Angiotensin II and Vascular Injury (2014) (291)
Reduced Vascular Remodeling, Endothelial Dysfunction, and Oxidative Stress in Resistance Arteries of Angiotensin II–Infused Macrophage Colony-Stimulating Factor–Deficient Mice: Evidence for a Role in Inflammation in Angiotensin-Induced Vascular Injury (2005) (285)
Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. (2014) (284)
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction (2012) (284)
c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells (2003) (281)
Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways (2001) (262)
Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. (2012) (261)
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. (2001) (259)
From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. (2004) (256)
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. (2012) (255)
Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice (2004) (252)
The role of infiltrating immune cells in dysfunctional adipose tissue (2017) (251)
Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications (2016) (249)
Role of magnesium in the pathogenesis of hypertension. (2003) (249)
Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling (2003) (248)
Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II (2005) (245)
Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. (2015) (244)
Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells (2007) (244)
Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association. (2016) (243)
Aldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-Src (2005) (241)
Redox‐dependent signalling by angiotensin II and vascular remodelling in hypertension (2003) (239)
Recent advances in angiotensin II signaling. (2002) (235)
Vascular biology of ageing—Implications in hypertension (2015) (232)
Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. (2011) (230)
PPARα Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation (2002) (229)
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) (2017) (228)
Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research. (2014) (226)
Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. (2005) (219)
Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart (2008) (217)
Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. (1999) (217)
Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician. (2012) (214)
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure (2019) (209)
Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells (2004) (209)
Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts (2011) (207)
Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. (2002) (207)
Vascular biology of endothelin. (1998) (204)
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study (2021) (201)
Docosahexaenoic Acid, a Peroxisome Proliferator–Activated Receptor-&agr; Ligand, Induces Apoptosis in Vascular Smooth Muscle Cells by Stimulation of p38 Mitogen-Activated Protein Kinase (2000) (199)
Effect of Peroxisome Proliferator–Activated Receptor-&agr; and -&ggr; Activators on Vascular Remodeling in Endothelin-Dependent Hypertension (2003) (197)
Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. (2012) (195)
Transient Receptor Potential Melastatin 7 Ion Channels Regulate Magnesium Homeostasis in Vascular Smooth Muscle Cells: Role of Angiotensin II (2005) (195)
Role of magnesium in hypertension. (2007) (185)
A new look at the renin–angiotensin system—Focusing on the vascular system (2011) (183)
May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension (2019) (182)
Vascular Smooth Muscle Cell Differentiation to an Osteogenic Phenotype Involves TRPM7 Modulation by Magnesium (2010) (182)
Reactive oxygen species in vascular biology: role in arterial hypertension (2003) (179)
Human endothelial colony-forming cells protect against acute kidney injury: role of exosomes. (2015) (179)
Oxidative stress, Noxs, and hypertension: Experimental evidence and clinical controversies (2012) (177)
Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension (2000) (174)
Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. (1999) (171)
Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients (2008) (170)
Magnesium in clinical medicine. (2004) (170)
Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. (2009) (167)
p47phox Associates With the Cytoskeleton Through Cortactin in Human Vascular Smooth Muscle Cells: Role in NAD(P)H Oxidase Regulation by Angiotensin II (2005) (167)
Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II – editorial review (2005) (163)
Aldosterone and Angiotensin II Synergistically Stimulate Migration in Vascular Smooth Muscle Cells Through c-Src–Regulated Redox-Sensitive RhoA Pathways (2008) (162)
Angiotensin II and the vascular phenotype in hypertension (2011) (161)
Role of endothelin in human hypertension. (2003) (160)
Oxidative stress and vascular damage in hypertension (2000) (159)
Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. (2008) (156)
Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. (2006) (154)
Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 5 (Nox5) Regulation by Angiotensin II and Endothelin-1 Is Mediated via Calcium/Calmodulin-Dependent, Rac-1–Independent Pathways in Human Endothelial Cells (2010) (152)
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. (2008) (151)
ETA Receptor Blockade Decreases Vascular Superoxide Generation in DOCA-Salt Hypertension (2003) (150)
Differential Calcium Regulation by Hydrogen Peroxide and Superoxide in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats (2004) (146)
Peroxisome Proliferator-Activated Receptor-&agr; and Receptor-&ggr; Activators Prevent Cardiac Fibrosis in Mineralocorticoid-Dependent Hypertension (2003) (145)
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. (2007) (145)
Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. (2013) (143)
Animal Models of Hypertension: A Scientific Statement From the American Heart Association (2019) (143)
Vascular Complications of Cancer Chemotherapy (2016) (142)
Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. (1999) (142)
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. (2011) (142)
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. (2009) (139)
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. (2006) (135)
Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling (2016) (135)
Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system. (2004) (133)
The role of angiotensin II in regulating vascular structural and functional changes in hypertension (2003) (131)
Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. (1999) (131)
Angiotensin II-Dependent Chronic Hypertension and Cardiac Hypertrophy Are Unaffected by gp91phox-Containing NADPH Oxidase (2005) (131)
Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive Patients (2007) (129)
Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries. (1999) (128)
Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs (2005) (127)
Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. (1995) (124)
Neonatal Oxygen Exposure in Rats Leads to Cardiovascular and Renal Alterations in Adulthood (2008) (124)
Systemic microvascular dysfunction in microvascular and vasospastic angina (2018) (123)
Loss of Lkb1 in adult beta cells increases beta cell mass and enhances glucose tolerance in mice. (2009) (123)
Ischemia and No Obstructive Coronary Artery Disease (2019) (121)
Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Receptor regulation and intracellular Ca2+ modulation. (1996) (119)
Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events (2018) (116)
Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. (2003) (115)
Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. (2006) (114)
Apocynin, NADPH oxidase, and vascular cells: a complex matter. (2008) (114)
Redox-Sensitive Signaling by Angiotensin II Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase SHP-2 in Vascular Smooth Muscle Cells From SHR (2008) (113)
Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats (2004) (112)
Src Is an Important Mediator of Extracellular Signal–Regulated Kinase 1/2–Dependent Growth Signaling by Angiotensin II in Smooth Muscle Cells From Resistance Arteries of Hypertensive Patients (2001) (112)
Persistent Remodeling of Resistance Arteries in Type 2 Diabetic Patients on Antihypertensive Treatment (2004) (112)
Reactive oxygen species and vascular remodelling in hypertension: still alive. (2006) (110)
Cell Signaling of Angiotensin II on Vascular Tone: Novel Mechanisms (2011) (107)
Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. (2008) (106)
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. (2010) (106)
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19 (2020) (106)
NOX isoforms and reactive oxygen species in vascular health. (2011) (105)
Oxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies (2012) (104)
NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy (2017) (104)
Oxidative Stress: A Unifying Paradigm in Hypertension (2020) (104)
Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome. (2014) (104)
Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice. (2007) (104)
Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells (2001) (103)
Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. (1997) (103)
Cardiotoxicity with vascular endothelial growth factor inhibitor therapy (2018) (102)
Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats. (2006) (102)
Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury. (2014) (101)
Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression. (2014) (101)
Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5. (2011) (101)
Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats. (1998) (101)
NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy. (2014) (101)
Increased Angiotensin II-Mediated Src Signaling via Epidermal Growth Factor Receptor Transactivation Is Associated With Decreased C-Terminal Src Kinase Activity in Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats (2002) (100)
Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. (2000) (100)
Downregulation of Renal TRPM7 and Increased Inflammation and Fibrosis in Aldosterone-Infused Mice: Effects of Magnesium (2008) (100)
PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. (2002) (99)
The 2004 Canadian recommendations for the management of hypertension: Part III--Lifestyle modifications to prevent and control hypertension. (2004) (98)
1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA) (2019) (98)
Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin‐1 (1994) (98)
Angiotensin Receptor Blocker Added to Previous Antihypertensive Agents on Arteries of Diabetic Hypertensive Patients (2006) (98)
c-Src–Dependent Nongenomic Signaling Responses to Aldosterone Are Increased in Vascular Myocytes From Spontaneously Hypertensive Rats (2005) (97)
Allopurinol and Cardiovascular Outcomes in Adults With Hypertension (2016) (97)
Downregulation of Nuclear Factor Erythroid 2–Related Factor and Associated Antioxidant Genes Contributes to Redox-Sensitive Vascular Dysfunction in Hypertension (2015) (95)
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. (2006) (95)
Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats (2005) (93)
Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. (2011) (91)
Clinical significance of endothelin in cardiovascular disease (1997) (91)
p38 MAP Kinase Regulates Vascular Smooth Muscle Cell Collagen Synthesis by Angiotensin II in SHR But Not in WKY (2001) (89)
Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders (2016) (86)
Testosterone Induces Vascular Smooth Muscle Cell Migration by NADPH Oxidase and c-Src–Dependent Pathways (2012) (85)
Effect of Hyperhomocystinemia and Hypertension on Endothelial Function in Methylenetetrahydrofolate Reductase–Deficient Mice (2003) (85)
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. (2005) (85)
Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. (2005) (84)
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease (2017) (82)
Recent advances in intracellular signalling in hypertension (2003) (82)
Microparticles Induce Cell Cycle Arrest Through Redox-Sensitive Processes in Endothelial Cells: Implications in Vascular Senescence (2012) (82)
Exercise reverses metabolic syndrome in high-fat diet-induced obese rats. (2011) (82)
Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation (2017) (81)
Angiotensin-(1–7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells (2009) (81)
Anti‐atherosclerotic effect of the angiotensin 1–7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis (2017) (80)
Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension. (1993) (80)
Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar–Kyoto rats and spontaneously hypertensive rats (2001) (80)
Renal Redox-Sensitive Signaling, but Not Blood Pressure, Is Attenuated by Nox1 Knockout in Angiotensin II–Dependent Chronic Hypertension (2008) (79)
Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications (2017) (78)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (77)
Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox (2015) (77)
Magnesium, calcium, sodium and potassium status in normotensive and hypertensive Johannesburg residents. (1987) (76)
Apocynin, Reduced Nicotinamide-Adenine Dinucleotide Phosphate Oxidase, and Vascular Cells. A Complex Matter (2007) (75)
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk. (2009) (75)
Modulation of vascular smooth muscle cell growth by magnesium—role of mitogen—activated protein kinases (2003) (75)
TRPM7, Magnesium, and Signaling (2019) (74)
Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase (2015) (73)
Effect of pressurization on mechanical properties of mesenteric small arteries from spontaneously hypertensive rats. (1997) (73)
Endothelin, sex and hypertension. (2008) (71)
Redox signaling, Nox5 and vascular remodeling in hypertension (2015) (70)
Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats: role of reactive oxygen species (2002) (70)
Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase (2006) (69)
Canadian hypertension education program 2006 recommendations (2006) (69)
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. (2022) (68)
Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. (2001) (67)
Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats (2002) (67)
Effect of magnesium on vascular tone and reactivity in pressurized mesenteric resistance arteries from spontaneously hypertensive rats. (1997) (67)
Adipocyte-Derived Factors Regulate Vascular Smooth Muscle Cells Through Mineralocorticoid and Glucocorticoid Receptors (2011) (67)
Vascular Nox (NADPH Oxidase) Compartmentalization, Protein Hyperoxidation, and Endoplasmic Reticulum Stress Response in Hypertension (2018) (67)
Dysregulation of Vascular TRPM7 and Annexin-1 Is Associated With Endothelial Dysfunction in Inherited Hypomagnesemia (2009) (66)
Lysyl Oxidase Induces Vascular Oxidative Stress and Contributes to Arterial Stiffness and Abnormal Elastin Structure in Hypertension: Role of p38MAPK. (2017) (66)
Regulation of the novel Mg2+ transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells (2009) (66)
Thioredoxin in vascular biology: role in hypertension. (2008) (65)
Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults (2019) (64)
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction. (2021) (63)
Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways. (1997) (63)
Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis (2019) (61)
Vascular Nox4: a multifarious NADPH oxidase. (2012) (61)
Multiple actions of angiotensin II in hypertension (2003) (61)
Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function. (2007) (60)
Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension. (2011) (59)
Magnesium supplementation attenuates, but does not prevent, development of hypertension in spontaneously hypertensive rats. (1999) (59)
Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition (2017) (59)
Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. (2020) (59)
ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. (2020) (57)
Angiotensin II and Vasopressin Modulate Intracellular Free Magnesium in Vascular Smooth Muscle Cells through Na+-dependent Protein Kinase C Pathways* (1996) (56)
VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive Processes (2018) (56)
Bradykinin regulates calpain and proinflammatory signaling through TRPM7-sensitive pathways in vascular smooth muscle cells. (2009) (56)
Small‐Vessel Disease in the Heart and Brain: Current Knowledge, Unmet Therapeutic Need, and Future Directions (2019) (55)
Molecular and cellular mechanisms regulating vascular function and structure--implications in the pathogenesis of hypertension. (2000) (55)
Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. (2014) (55)
NOX5: Molecular biology and pathophysiology (2019) (54)
Role of calcium influx and intracellular calcium stores in angiotensin II‐mediated calcium hyper‐responsiveness in smooth muscle from spontaneously hypertensive rats (1997) (53)
Differential regulation of thioredoxin and NAD(P)H oxidase by angiotensin II in male and female mice (2007) (53)
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune–inflammatory responses in diabetic Apoe−/− mice (2014) (53)
Pseudohyperaldosteronism, Liquorice, and Hypertension (2008) (53)
ETA Receptor Mediates Altered Leukocyte-Endothelial Cell Interaction and Adhesion Molecules Expression in DOCA–Salt Rats (2004) (53)
Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women (2017) (52)
Personalized medicine—a modern approach for the diagnosis and management of hypertension (2017) (52)
Chronic Production of Angiotensin IV in the Brain Leads to Hypertension That Is Reversible With an Angiotensin II AT1 Receptor Antagonist (2004) (52)
Critical role of Nox 4-based NADPH oxidase in glucose-induced oxidative stress in the kidney : implications in type 2 diabetic nephropathy (2010) (52)
Activation of the Na(+)-H+ exchanger modulates angiotensin II-stimulated Na(+)-dependent Mg2+ transport in vascular smooth muscle cells in genetic hypertension. (1999) (51)
Acute ethanol intake induces superoxide anion generation and mitogen-activated protein kinase phosphorylation in rat aorta: a role for angiotensin type 1 receptor. (2012) (51)
Vasoactive peptides in cardiovascular (patho)physiology (2007) (51)
Allopurinol Initiation and Change in Blood Pressure in Older Adults With Hypertension (2014) (51)
Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction (2020) (50)
Endothelin A Receptor Blockade Decreases Expression of Growth Factors and Collagen and Improves Matrix Metalloproteinase-2 Activity in Kidneys from Stroke-Prone Spontaneously Hypertensive Rats (2002) (50)
Candidate Genes That Determine Response to Salt in the Stroke-Prone Spontaneously Hypertensive Rat: Congenic Analysis (2007) (50)
Vascular Biology of Superoxide-Generating NADPH Oxidase 5—Implications in Hypertension and Cardiovascular Disease (2019) (50)
Vascular proinflammatory responses by aldosterone are mediated via c-Src trafficking to cholesterol-rich microdomains: role of PDGFR. (2011) (50)
Inflammation and vascular hypertrophy induced by angiotensin II: role of NADPH oxidase-derived reactive oxygen species independently of blood pressure elevation? (2003) (50)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (49)
Tyrosine kinase signaling pathways modulate angiotensin II-induced calcium ([Ca2+]i) transients in vascular smooth muscle cells. (1996) (49)
Endothelin-1, but not Ang II, Activates MAP Kinases Through c-Src–Independent Ras-Raf–Dependent Pathways in Vascular Smooth Muscle Cells (2007) (49)
Intracellular Mg2+, Ca2+, Na2+ and K+ in platelets and erythrocytes of essential hypertension patients: relation to blood pressure. (1992) (48)
Magnesium transport in hypertension. (2007) (47)
Insulin Attenuates Agonist‐Evoked Calcium Transients in Vascular Smooth Muscle Cells (1994) (47)
High Fat Diet Attenuates the Anticontractile Activity of Aortic PVAT via a Mechanism Involving AMPK and Reduced Adiponectin Secretion (2018) (47)
Adipocytes, aldosterone and obesity-related hypertension. (2016) (47)
Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors. (1996) (47)
Drug Treatment of Hypertension: Focus on Vascular Health (2016) (47)
NADPH Oxidase 5 Is a Pro‐Contractile Nox Isoform and a Point of Cross‐Talk for Calcium and Redox Signaling‐Implications in Vascular Function (2018) (47)
Endothelial Microparticle-Derived Reactive Oxygen Species: Role in Endothelial Signaling and Vascular Function (2016) (46)
Vascular signaling through cholesterol-rich domains: implications in hypertension (2007) (45)
Interleukin-18 Enhances Vascular Calcification and Osteogenic Differentiation of Vascular Smooth Muscle Cells Through TRPM7 Activation (2017) (45)
Mitogen-activated protein kinase activation by hydrogen peroxide is mediated through tyrosine kinase-dependent, protein kinase C-independent pathways in vascular smooth muscle cells: upregulation in spontaneously hypertensive rats (2005) (45)
Assessment and pathophysiology of microvascular disease: recent progress and clinical implications (2020) (45)
Acute effects of electronic and tobacco cigarettes on vascular and respiratory function in healthy volunteers: a cross-over study (2018) (45)
Intracellular Ca2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats. (1996) (45)
Tissue sodium excess is not hypertonic and reflects extracellular volume expansion (2020) (44)
Modulation of Ca2+ transients in neonatal and adult rat cardiomyocytes by angiotensin II and endothelin-1. (1996) (44)
Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure. (2007) (44)
Aldosterone, SGK1, and ion channels in the kidney (2018) (44)
The effect of angiotensin II on platelet intracellular free magnesium and calcium ionic concentrations in essential hypertension (1993) (43)
Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis (2017) (43)
Oxidative Stress and Hypertension (2021) (43)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (42)
Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors (2018) (42)
Alterations in intracellular cations and cell membrane ATPase activity in patients with malignant hypertension (1995) (42)
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. (2007) (41)
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. (2006) (41)
Contribution of endothelin-1 to renal activator protein-1 activation and macrophage infiltration in aldosterone-induced hypertension. (2002) (40)
Sphingosine-1-Phosphate-Induced Inflammation Involves Receptor Tyrosine Kinase Transactivation in Vascular Cells: Upregulation in Hypertension (2011) (40)
The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. (2002) (40)
Serotonin Signaling Through the 5-HT1B Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension (2017) (39)
Dysregulation of renal transient receptor potential melastatin 6/7 but not paracellin-1 in aldosterone-induced hypertension and kidney damage in a model of hereditary hypomagnesemia (2011) (39)
Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages (2011) (39)
Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology. (2016) (39)
Vascular Smooth Muscle Cell Differentiation to an Osteogenic Phenotype Involves TRPM 7 Modulation by Magnesium (2010) (39)
Notch3 signalling and vascular remodelling in pulmonary arterial hypertension (2019) (39)
Vascular biology of magnesium and its transporters in hypertension. (2010) (39)
Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Mediated Redox Signaling and Vascular Remodeling by 16α-Hydroxyestrone in Human Pulmonary Artery Cells (2016) (38)
Cyclic GMP Inhibits a Pharmacologically Distinct Na+/H+ Exchanger Variant in Cultured Rat Astrocytes via an Extracellular Site of Action (1997) (38)
T Cells Are Dominant Population in Human Abdominal Aortic Aneurysms and Their Infiltration in the Perivascular Tissue Correlates With Disease Severity (2019) (37)
Altered angiotensin II-induced small artery contraction during the development of hypertension in spontaneously hypertensive rats. (1999) (37)
Magnesium and hypertension (2006) (37)
Ethanol-induced vasoconstriction is mediated via redox-sensitive cyclo-oxygenase-dependent mechanisms. (2010) (37)
Global survey of current practice in management of hypertension as reported by societies affiliated with the international society of hypertension (2013) (37)
Endothelial Cells Negatively Modulate Reactive Oxygen Species Generation in Vascular Smooth Muscle Cells: Role of Thioredoxin (2009) (37)
Growth factors mediate intracellular signaling in vascular smooth muscle cells through protein kinase C-linked pathways. (1997) (37)
alpha 8 Integrin overexpression in de-differentiated vascular smooth muscle cells attenuates migratory activity and restores the characteristics of the differentiated phenotype. (2007) (36)
The Meaning of Mas (2018) (36)
Endothelial Gata5 transcription factor regulates blood pressure (2015) (36)
Temporal changes in cardiac oxidative stress, inflammation and remodeling induced by exercise in hypertension: Role for local angiotensin II reduction (2017) (36)
Platelet and erythrocyte Mg2+, Ca2+, Na+, K+ and cell membrane adenosine triphosphatase activity in essential hypertension in blacks (1992) (36)
Testosterone induces leucocyte migration by NADPH oxidase-driven ROS- and COX2-dependent mechanisms. (2015) (36)
The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. (2001) (35)
Reactive oxygen species and hypertension: a complex association. (2008) (35)
Brown Adipose Tissue Regulates Small Artery Function Through NADPH Oxidase 4–Derived Hydrogen Peroxide and Redox-Sensitive Protein Kinase G-1&agr; (2017) (35)
Internal Pudental Artery Dysfunction in Diabetes Mellitus Is Mediated by NOX1-Derived ROS-, Nrf2-, and Rho Kinase–Dependent Mechanisms (2016) (35)
Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats. (1998) (35)
Acute ethanol intake induces mitogen-activated protein kinase activation, platelet-derived growth factor receptor phosphorylation, and oxidative stress in resistance arteries (2014) (35)
Effects of AGTR1 A1166C Gene Polymorphism in Patients with Heart Failure Treated with Candesartan (2008) (35)
Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets? (2016) (35)
A Call to Regulate Manufacture and Marketing of Blood Pressure Devices and Cuffs: A Position Statement From the World Hypertension League, International Society of Hypertension and Supporting Hypertension Organizations (2016) (34)
Adipocyte-Specific Mineralocorticoid Receptor Overexpression in Mice Is Associated With Metabolic Syndrome and Vascular Dysfunction: Role of Redox-Sensitive PKG-1 and Rho Kinase (2016) (34)
Inhibitors of Na+/Mg2+ exchange activity attenuate the development of hypertension in angiotensin II-induced hypertensive rats (2003) (34)
Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways. (2015) (34)
Tissue Targeting of Angiotensin Peptides* (1997) (34)
Acetaminophen Use and Risk of Myocardial Infarction and Stroke in a Hypertensive Cohort (2015) (34)
Expression of NAD(P)H Oxidase Subunits and Their Contribution to Cardiovascular Damage in Aldosterone/Salt-Induced Hypertensive Rat (2008) (34)
Effect of magnesium on calcium responses to vasopressin in vascular smooth muscle cells of spontaneously hypertensive rats. (1998) (34)
Attenuated Responses to Angiotensin II in Follitropin Receptor Knockout Mice, a Model of Menopause-Associated Hypertension (2003) (33)
High Blood Pressure 2016: Why Prevention and Control Are Urgent and Important. The World Hypertension League, International Society of Hypertension, World Stroke Organization, International Diabetes Foundation, International Council of Cardiovascular Prevention and Rehabilitation, International Soci (2016) (33)
Isolation and Differentiation of Murine Macrophages. (2017) (33)
Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction (2016) (33)
Evolution of a New Class of Antihypertensive Drugs: Targeting the Brain Renin-Angiotensin System. (2019) (33)
The Serotonin Transporter Promotes a Pathological Estrogen Metabolic Pathway in Pulmonary Hypertension via Cytochrome P450 1B1 (2016) (32)
Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus. (2015) (32)
Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade. (2003) (32)
Synergistic vascular protective effects of combined low doses of PPARα and PPARγ activators in angiotensin II‐induced hypertension in rats (2007) (32)
Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling (2015) (31)
Exercise training protects against atherosclerotic risk factors through vascular NADPH oxidase, extracellular signal‐regulated kinase 1/2 and stress‐activated protein kinase/c‐Jun N‐terminal kinase downregulation in obese rats (2015) (31)
Structural features and expression of an alternatively spliced growth factor type I receptor for follitropin signaling in the developing ovary. (1999) (31)
Differential renal effects of candesartan at high and ultra-high doses in diabetic mice–potential role of the ACE2/AT2R/Mas axis (2016) (31)
Adventitia-derived hydrogen peroxide impairs relaxation of the rat carotid artery via smooth muscle cell p38 mitogen-activated protein kinase. (2011) (31)
Vascular remodeling, retinal arteries, and hypertension. (2007) (30)
PARK7/DJ-1 dysregulation by oxidative stress leads to magnesium deficiency: implications in degenerative and chronic diseases. (2015) (30)
ER stress and Rho kinase activation underlie the vasculopathy of CADASIL (2019) (30)
Angiotensin II Type I Receptor Modulates Intracellular Free Mg2+ in Renally Derived Cells via Na+-dependent Ca2+-independent Mechanisms* (2001) (29)
The World Hypertension League and International Society of Hypertension Call on Governments, Nongovernmental Organizations, and the Food Industry to Work to Reduce Dietary Sodium (2014) (29)
Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats. (1995) (29)
Lipid rafts take center stage in endothelial cell redox signaling by death receptors. (2006) (29)
Follicle-Stimulating Hormone Mediated Calcium Signaling by the Alternatively Spliced Growth Factor Type I Receptor1 (2000) (29)
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study (2020) (28)
Involvement of Oxidative Stress in the Profibrotic Action of Aldosterone Interaction With the Renin-Angiotensin System (2004) (28)
Aldosterone signaling through transient receptor potential melastatin 7 cation channel (TRPM7) and its α-kinase domain. (2013) (27)
Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 5 ( Nox 5 ) Regulation by Angiotensin II and Endothelin-1 Is Mediated via Calcium / Calmodulin-Dependent , Rac1 – Independent Pathways in Human Endothelial Cells (2010) (27)
Successes of SPRINT, but Still Some Hurdles to Cross. (2016) (27)
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling (2018) (27)
Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells. (2005) (27)
Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats (2002) (27)
Mitochondrial redox control of matrix metalloproteinase signaling in resistance arteries. (2006) (26)
Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension. (2014) (26)
Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction (2020) (26)
An Interaction of Renin-Angiotensin and Kallikrein-Kinin Systems Contributes to Vascular Hypertrophy in Angiotensin II-Induced Hypertension: In Vivo and In Vitro Studies (2014) (26)
Applying the 2005 Canadian Hypertension Education Program recommendations: 3. Lifestyle modifications to prevent and treat hypertension (2005) (25)
Patient-Specific iPSC Model of a Genetic Vascular Dementia Syndrome Reveals Failure of Mural Cells to Stabilize Capillary Structures (2019) (25)
Ethanol induces vascular relaxation via redox-sensitive and nitric oxide-dependent pathways. (2012) (25)
Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR/GR) (2014) (25)
Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy (2020) (25)
c-Src Inhibition Improves Cardiovascular Function but not Remodeling or Fibrosis in Angiotensin II–Induced Hypertension (2016) (25)
Angiotensin-(1-7) and Vascular Function: The Clinical Context. (2018) (25)
Increased inflammatory biomarkers in hypertensive type 2 diabetic patients: improvement after angiotensin II type 1 receptor blockade. (2007) (24)
Up-regulation of vascular and renal mitogen-activated protein kinases in hypertensive rats is normalized by inhibitors of the Na+/Mg2+ exchanger. (2003) (24)
Blunted inhibition by insulin of agonist‐stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients (1994) (24)
Activation of vascular p38MAPK by mechanical stretch is independent of c-Src and NADPH oxidase: influence of hypertension and angiotensin II. (2012) (23)
Reactive oxygen species, cell growth, cell cycle progression and vascular remodeling in hypertension. (2007) (23)
Characterization of myocardium, isolated cardiomyocytes, and blood pressure in WKHA and WKY rats. (2002) (23)
Chemerin receptor blockade improves vascular function in diabetic obese mice via redox-sensitive and Akt-dependent pathways. (2018) (23)
Cardiac type-1 angiotensin II receptor status in deoxycorticosterone acetate-salt hypertension in rats. (1997) (23)
Racial differences in cell membrane ATPases and cellular cation content in urban South African normotensive and hypertensive subjects. (1993) (23)
Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse (2019) (23)
Crosstalk Between Vascular Redox and Calcium Signaling in Hypertension Involves TRPM2 (Transient Receptor Potential Melastatin 2) Cation Channel. (2019) (23)
Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury (2019) (22)
Insulin-induced Ca2+ transport is altered in vascular smooth muscle cells of spontaneously hypertensive rats. (1994) (22)
Signaling of angiotensin II-induced vascular protein synthesis in conduit and resistance arteries in vivo (2004) (22)
Chapter 30 – Reactive Oxygen Species, Oxidative Stress, and Vascular Biology in Hypertension (2007) (22)
Endothelial cell IL-8, a new target for adiponectin: implications in vascular protection. (2005) (22)
Is It Time to Reappraise Blood Pressure Thresholds and Targets? A Statement From the International Society of Hypertension-A Global Perspective. (2016) (22)
Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial☆☆☆ (2018) (22)
Receptor and nonreceptor tyrosine kinases in vascular biology of hypertension (2010) (22)
Potentiation of vascular oxidative stress and nitric oxide-mediated endothelial dysfunction by high-fat diet in a mouse model of estrogen deficiency and hyperandrogenemia. (2009) (22)
Endothelin-A-receptor blockade improves renal function and doubles the lifespan of stroke-prone spontaneously hypertensive rats. (2000) (21)
The Canadian Hypertension Education Program - a unique Canadian knowledge translation program. (2007) (21)
Hypertension Guidelines: More Challenges Highlighted by Europe (2013) (21)
Isolation and Culture of Vascular Smooth Muscle Cells from Small and Large Vessels. (2017) (20)
Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells (2016) (20)
Activated oxygen metabolites: do they really play a role in angiotensin II-regulated vascular tone? (2003) (20)
The International Society of Hypertension and World Hypertension League call on governments, nongovernmental organizations and the food industry to work to reduce dietary sodium. (2014) (20)
Mesenteric vascular smooth muscle cells from SHR display increased Ca 2+ responses to angiotensin II but not to endothelin-1 (1994) (20)
Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in Hypertension (2004) (19)
A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques (2021) (19)
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension (2020) (19)
Vascular toxicity associated with anti-angiogenic drugs. (2020) (19)
Enhanced Expression of Endothelin‐1 Gene May Cause Blood Pressure‐Independent Vascular Hypertrophy (1995) (19)
Endothelin influences pHi of human platelets through protein kinase C mediated pathways. (1995) (19)
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014)) (2019) (19)
ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease (2021) (19)
PTGER1 deletion attenuates renal injury in diabetic mouse models. (2013) (19)
Cardiotoxic effects of angiogenesis inhibitors (2021) (19)
Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress (2019) (19)
Altered cations and muscle membrane ATPase activity in deoxycorticosterone acetate-salt spontaneously hypertensive rats. (1991) (18)
Downregulated Serum 14, 15-Epoxyeicosatrienoic Acid Is Associated With Abdominal Aortic Calcification in Patients With Primary Aldosteronism (2018) (18)
Short Daily versus Conventional Hemodialysis for Hypertensive Patients: A Randomized Cross-Over Study (2014) (18)
Altered cardiac endothelin receptors and protein kinase C in deoxycorticosterone-salt hypertensive rats. (2000) (18)
Differential effects of vasopressin and endothelin‐1 on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats (1996) (18)
Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3 (2016) (18)
Ca2+-Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production (2020) (18)
Aldosterone Upregulates Transient Receptor Potential Melastatin 7 (TRPM7)* (2016) (18)
New insights into mechanisms of hypertension. (2012) (18)
Are the American Heart Association/American College of Cardiology High Blood Pressure Guidelines Fit for Global Purpose?: Thoughts From the International Society of Hypertension. (2018) (18)
Cholesteryl Ester-Transfer Protein Inhibitors Stimulate Aldosterone Biosynthesis in Adipocytes through Nox-Dependent Processes (2015) (17)
Recommended standards for assessing blood pressure in human research where blood pressure or hypertension is a major focus (2017) (17)
The effect of angiotensin-(1-7) in mouse unilateral ureteral obstruction. (2015) (17)
Changes in Cardiopulmonary Reserve and Peripheral Arterial Function Concomitantly with Subclinical Inflammation and Oxidative Stress in Patients with Heart Failure with Preserved Ejection Fraction (2014) (17)
Transient Receptor Potential Melastatin 7 Cation Channel Kinase: New Player in Angiotensin II-Induced Hypertension. (2016) (17)
Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study (2018) (16)
Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in rats. (2007) (16)
Inhibitory effects of PPAR-gamma on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats. (2007) (16)
A multisystem, cardio-renal investigation of post-COVID-19 illness (2022) (16)
Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table (2019) (16)
Human cord blood CD133+ cells exacerbate ischemic acute kidney injury in mice. (2012) (16)
Antiproliferative effect of L-NAME on rat vascular smooth muscle cells. (2000) (16)
Upregulation of Nrf2 and Decreased Redox Signaling Contribute to Renoprotective Effects of Chemerin Receptor Blockade in Diabetic Mice (2018) (16)
Vitamin C prevents the endothelial dysfunction induced by acute ethanol intake. (2015) (15)
Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways (1999) (15)
Expression of Cell Cycle Proteins in Blood Vessels of Angiotensin II–Infused Rats: Role of AT1 Receptors (2001) (15)
Isolation and Differentiation of Human Macrophages. (2017) (15)
Relations between magnesium, calcium, and plasma renin activity in black and white hypertensive patients. (1995) (15)
2016 Dietary Salt Fact Sheet and Call to Action: The World Hypertension League, International Society of Hypertension, and the International Council of Cardiovascular Prevention and Rehabilitation (2016) (15)
Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause. (2008) (15)
Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer (2020) (15)
ENDOTHELIN‐1 GENE EXPRESSION AND VASCULAR HYPERTROPHY IN DOCA‐SALT HYPERTENSION COMPARED TO SPONTANEOUSLY HYPERTENSIVE RATS (1995) (15)
Altered vascular structure and wave reflection in hypertensive women with low magnesium levels. (2013) (15)
Novel Biosensors Reveal a Shift in the Redox Paradigm From Oxidative to Reductive Stress in Heart Disease. (2016) (14)
Networking between systemic angiotensin II and cardiac mineralocorticoid receptors. (2008) (14)
Role of α1D -adrenoceptors in vascular wall hypertrophy during angiotensin II-induced hypertension. (2015) (14)
Selective ETA versus dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats. (2020) (14)
Moderate exercise decreases inflammation and oxidative stress in hypertension: but what are the mechanisms? (2009) (14)
Much Ado about N…atrium: modelling tissue sodium as a highly sensitive marker of subclinical and localized oedema (2018) (14)
Sex steroids receptors, hypertension, and vascular ageing (2021) (13)
Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension (2020) (13)
Increased blood pressure, vascular inflammation, and endothelial dysfunction in androgen-deficient follitropin receptor knockout male mice. (2007) (13)
Endothelin receptor subtypes in mesenteric vascular smooth muscle cells of spontaneously hypertensive rats. (1995) (13)
Redox Stress Defines the Small Artery Vasculopathy of Hypertension: How Do We Bridge the Bench-to-Bedside Gap? (2017) (13)
Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension (2006) (13)
Regulation of endothelial nitric oxide synthase by thrombin. (2007) (13)
A method for determining the total magnesium, calcium, sodium and potassium contents of human platelets. (1991) (13)
Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A (2012) (13)
Role of angiotensin II type 2 receptor during regression of cardiac hypertrophy in spontaneously hypertensive rats. (2013) (12)
Management of a Pregnant Woman With Fibromuscular Dysplasia. (2018) (12)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (12)
Cardiac signaling molecules and plasma biomarkers after cardiac transplantation: impact of tacrolimus versus cyclosporine. (2013) (12)
Lysophosphatidylcholine induces oxidative stress in human endothelial cells via NOX5 activation - implications in atherosclerosis. (2021) (12)
Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” [Redox Biol. 13 (2017) 94–162] (2017) (12)
Hypertension Guidelines: Effect of Blood Pressure Targets. (2019) (11)
A four-dimensional computational model of dynamic contrast-enhanced magnetic resonance imaging measurement of subtle blood-brain barrier leakage (2020) (11)
Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19 (2021) (11)
A method for measuring intracellular free magnesium concentration in platelets using flow cytometry. (2007) (11)
Central role of c-Src in NOX5- mediated redox signalling in vascular smooth muscle cells in human hypertension (2021) (11)
Local endothelial dna repair defect causes aging-resembling endothelial-specific dysfunction. (2020) (11)
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis (2021) (11)
Cardiotoxicity and myocardial hypoperfusion associated with anti‐vascular endothelial growth factor therapies: prospective cardiac magnetic resonance imaging in patients with cancer (2020) (11)
ETA AND ETB RECEPTORS ON VASCULAR SMOOTH MUSCLE CELLS FROM MESENTERIC VESSELS OF SPONTANEOUSLY HYPERTENSIVE RATS (1995) (11)
A new look at the eye: aldosterone and mineralocorticoid receptors as novel targets in retinal vasculopathy. (2008) (11)
Blunted attenuation of angiotensin II-mediated Ca2+ transients by insulin in cultured unpassaged vascular smooth muscle cells from spontaneously hypertensive rats. (1995) (11)
Recommendation on an updated standardization of serum magnesium reference ranges (2022) (11)
Endothelin-1 and vasopressin signalling in blood vessels of young SHR in comparison to adult SHR. (1996) (11)
Epidermal growth factor signaling through transient receptor potential melastatin 7 cation channel regulates vascular smooth muscle cell function (2020) (11)
PARP-1 (Poly[ADP-Ribose] Polymerase-1). (2018) (11)
Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: Protocol (2020) (10)
Signal transduction in hypertension: Part II. (1993) (10)
Basal and angiotensin II-induced cytosolic free calcium in adult rat cardiomyocytes and fibroblasts after volume overload. (1995) (10)
Off-Target Vascular Effects of Cholesteryl Ester Transfer Protein Inhibitors Involve Redox-Sensitive and Signal Transducer and Activator of Transcription 3–Dependent Pathways (2016) (10)
Characterization of constitutive and acid-induced outwardly rectifying chloride currents in immortalized mouse distal tubular cells (2017) (10)
Calcium, magnesium, and oxidative stress in hyperaldosteronism. (2005) (10)
Expression of cell cycle proteins in blood vessels of angiotensin II-infused rats: role of AT(1) receptors. (2001) (10)
Importance of cholesterol-rich microdomains in the regulation of Nox isoforms and redox signaling in human vascular smooth muscle cells (2020) (9)
Role of protein kinase C in the anti-aggregatory effects of endothelin-1 on human platelets. (1995) (9)
Nox 1 Plays a Key Role in Diabetes Accelerated Atherosclerosis (2013) (9)
Hypoglycemia associated with a lung mass. (1986) (9)
Magnesium, Vascular Function, and Hypertension (2016) (8)
SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension. (2004) (8)
Oxidative Stress in Arterial Hypertension: Oxidative Stress and Hypertension (2008) (8)
Aldosterone and Ion Channels. (2019) (8)
Vascular smooth muscle cells sense calcium: a new paradigm in vascular calcification. (2008) (8)
Interferon stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin II infused mice through increased oxidative stress. (2021) (8)
Transient Receptor Potential Melastatin 7 Cation Channel KinaseNovelty and Significance (2016) (8)
Differential effects of vasopressin and endothelin-1 on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats (1996) (7)
Progenitor Cells, Bone Marrow-Derived Fibrocytes and Endothelial-to-Mesenchymal Transition: New Players in Vascular Fibrosis. (2016) (7)
LB01.03: INCIDENCE AND PROGNOSIS OF CANCER ASSOCIATED WITH DIGOXIN AND COMMON ANTIHYPERTENSIVE DRUGS (2015) (7)
Position of Src tyrosine kinases in the interaction between angiotensin II and endothelin in in vivo vascular protein synthesis (2005) (7)
Protecting the Heart in Obesity: Role of ACE2 and Its Partners (2015) (7)
Presence of functionally active mg2+ uptake channels, TRPM6 and TRPM7, in vascular smooth muscle cells from WKY and SHR– differential regulation by aldosterone and angiotensin II (2004) (7)
Modulation of Ca2+ Transients in Neonatal and Adult Rat Cardiomyocytes by Endothelin‐1 (1995) (7)
Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (7)
Linking LOX-1 and arginase II through mitochondria: a novel paradigm in endothelial dysfunction. (2014) (7)
Biomarkers of Oxidative Stress in Human Hypertension (2016) (7)
Exosomes and the cardiovascular system: role in cardiovascular health and disease. (2022) (7)
Acute Ethanol Intake Induces NAD(P)H Oxidase Activation and Rhoa Translocation in Resistance Arteries (2016) (7)
Migrating Populations and Health: Risk Factors for Cardiovascular Disease and Metabolic Syndrome (2022) (6)
Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-sensitive Pathways. (2022) (6)
Extracellular Vesicles as Biomarkers and Biovectors in Primary Aldosteronism. (2019) (6)
Ca2+ and Contractile Responses of Resistance Vessels of WKY Rats and SHR to Endothelin‐1 (1995) (6)
Hypertension, Diabetes Mellitus, and Excess Cardiovascular Risk: Importance of Baseline Systolic Blood Pressure. (2017) (6)
Activator Effects on Ang II – Induced Vascular Oxidative Stress and Inflammation (2002) (6)
Blood Pressure Regulation and Pathology (2014) (6)
Highlights and summary of the 2006 Canadian Hypertension Education Program recommendations. (2006) (6)
Exercise aggravates cardiovascular risks and mortality in rats with disrupted nitric oxide pathway and treated with recombinant human erythropoietin (2011) (6)
The Neuroimmune Axis in the Kidney: Role in Hypertension. (2015) (6)
Analysis of dynamic texture and spatial spectral descriptors of dynamic contrast-enhanced brain magnetic resonance images for studying small vessel disease (2019) (6)
Analysis of Spatial Spectral Features of Dynamic Contrast-Enhanced Brain Magnetic Resonance Images for Studying Small Vessel Disease (2019) (6)
Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (6)
Celebrate World Hypertension Day (WHD) on May 17, 2015, and Contribute to Improving Awareness of Hypertension (2015) (6)
Impaired vasorelaxation in hypertension: beyond the endothelium. (2002) (6)
Hypertension, alcohol and cations in urban black and coloured South Africans. (1989) (6)
Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO∕sGC∕cGMP pathway. (2021) (5)
Biomarkers in Hypertension (2012) (5)
Treatment of non-insulin-dependent diabetic hypertensive patients with Ca2+ channel blockers is associated with increased platelet sensitivity to insulin. (1995) (5)
Muscarinic Receptor Type-3 in Hypertension and Cholinergic-Adrenergic Crosstalk: Genetic Insights and Potential for New Antihypertensive Targets (2019) (5)
Endothelin-1 signaling is altered in cardiac cells from deoxycorticosterone acetate-salt hypertensive rats. (1998) (5)
Magnesium supplementation as an adjuvant to synthetic calcium channel antagonists in the treatment of hypertension. (1991) (5)
Vascular Function in Health and Disease (2014) (5)
Lifestyle modifications to prevent and manage hypertension for exercise physiologists and fitness professionals. (2005) (5)
Aldosterone/MR Signaling, Oxidative Stress, and Vascular Dysfunction (2019) (5)
Apocynin, NADPH Oxidase, and Vascular Cells (2008) (5)
Biology of Blood Vessels in Hypertension (1993) (5)
Case of Refractory Hypertension Controlled by Repeated Renal Denervation and Celiac Plexus Block: A Case of Refractory Sympathetic Overload. (2017) (5)
Mammalian target of rapamycin: a novel pathway in vascular calcification. (2014) (5)
Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review (2020) (4)
Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD) (2020) (4)
The relationship between magnesium, calcium, sodium, potassium and blood pressure in South African adult males. (1989) (4)
Src modulates Ang II-mediated Ca2+ signaling in human vascular smooth muscle cells (1999) (4)
A Framework for Jointly Assessing and Reducing Imaging Artefacts Automatically Using Texture Analysis and Total Variation Optimisation for Improving Perivascular Spaces Quantification in Brain Magnetic Resonance Imaging (2020) (4)
New insights into molecular mechanisms of hypertension. (2010) (4)
An assessment of internship at the teaching hospitals of the University of the Witwatersrand. (1988) (4)
Myocyte growth, repair, and oxidative stress following pediatric heart transplantation (2014) (4)
Tyrosine Kinase Inhibition Attenuates Vasopressin-induced Contraction of Mesenteric Resistance Arteries: Alterations in Spontaneously Hypertensive Rats (2002) (4)
Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin) (2021) (4)
Magnesium and Other Biometals in Oxidative Medicine and Redox Biology (2017) (4)
Reactive Oxygen Species and Oxidative Stress (2012) (4)
Altered calcium binding to erythrocyte membranes in essential hypertension: relation to magnesium. (1993) (4)
Microglia, the Missing Link in the Brain-Gut-Hypertension Axis. (2019) (4)
Relation of serum uric acid to an exaggerated systolic blood pressure response to exercise testing in men with normotension (2018) (4)
Signal transduction in hypertension: Part I. (1993) (4)
Mechanosensitive regulation of cortactin by p47phox: a new paradigm in cytoskeletal remodeling. (2013) (4)
Circadian blood pressure variability in essential and secondary hypertension (1990) (4)
Hypertension and Antiangiogenesis (2019) (3)
Case of Asymptomatic Carotid Artery Stenosis in a Hypertensive Patient. (2017) (3)
Androgen and androgen receptors as determinants of vascular sex differences across the lifespan. (2022) (3)
Angiotensin II and Inflammation (2007) (3)
A New Look At the Mosaic Theory of Hypertension. (2020) (3)
Lessons Learned From RAG-1-Deficient Mice in Hypertension. (2020) (3)
A Cardiac and a Kidney Transplant Patient Above 6000 Meters in Bolivia (2009) (3)
Renin–angiotensin–aldosterone system: new concepts (2013) (3)
Gut Dysbiosis-Induced Hypertension Is Ameliorated by Intermittent Fasting. (2021) (3)
Abstract 258: Angiotensin 1-7 Attenuates Endothelin-1-Induced Endothelial Cell Inflammation and Growth Through Nitric Oxide Production and Activation of Mas and EndothelinB Receptors (2012) (3)
Metabolic Syndrome Sinkholes: What to Do When Occam's Razor Gets Blunted. (2015) (3)
ANTIHYPERTENSIVE TREATMENT Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin) A Potential New Therapy for Hypertension (2021) (3)
Acute vascular effects of vascular endothelial growth factor inhibition in the forearm arterial circulation (2019) (3)
Interplay Between Statins, Cav1 (Caveolin-1), and Aldosterone (2020) (3)
Assessment of perivascular space filtering methods using a three-dimensional computational model. (2022) (3)
Renovascular Hypertension: One Size Does Not Fit All: Challenges in Diagnosis and Management. (2021) (3)
Faculty Opinions recommendation of Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. (2009) (2)
Reactive Oxygen Species and the Cardiovascular System (2012) (2)
Council for [corrected] High Blood Pressure Research/InterAmerican Society of Hypertension/International Society of Hypertension: [corrected] first New Investigators Symposium at the High Blood Pressure Research 2011 Scientific Sessions. (2012) (2)
JS ISH-ECCR-2 ANG-(1-7) AND ET-1, A NEW PARTNERSHIP. (2016) (2)
Hypertension Editors Welcome Comments From Regional Hypertension Societies. (2018) (2)
Vascular progenitor recruitment in critically ill patients with acute kidney injury. (2011) (2)
The effect of magnesium sulphate infusion on circulating catecholamine levels in severe gestational proteinuric hypertension. A report of 8 cases. (1990) (2)
Advancement in hypertension pathogenesis: some new concepts. (2011) (2)
Vascular dysfunction and increased cardiovascular risk in hypospadias. (2022) (2)
Twenty-four hour ambulatory blood pressure in therapeutically resistant hypertensive patients. (1990) (2)
P38 MAP Kinase Regulates Vascular Smooth Muscle Cell (VSMC) Collagen Synthesis by Ang II in Shr But not in Wky. (2000) (2)
Biomarkers Of vascular inflammation and cardiovascular disease (2015) (2)
Assessment of Protein Carbonylation and Protein Tyrosine Phosphatase (PTP) Oxidation in Vascular Smooth Muscle Cells (VSMCs) Using Immunoblotting Approaches. (2017) (2)
Pressure-induced expression of vascular neuronal nitric oxide synthase: adaptive or maladaptive response in arteries? (2003) (2)
151 Nox5 induces vascular dysfunction and arterial remodelling independently of blood pressure elevation in ang ii-infused nox5-expressing mice (2017) (2)
A Compendium on Hypertension: New Advances and Future Impact. (2021) (2)
JS ISH-ECCR-2 ANG-(1-7) AND ET-1, A NEW PARTNERSHIP. (2016) (2)
Reactive oxygen species and other mediators of oxidative stress (2003) (2)
Lower is better in hypertension, but how low should blood pressure be targeted? (2016) (2)
AMPK as a therapeutic target for metabolic disorders: interactions with the renin–angiotensin–aldosterone system in adipocytes (2016) (2)
Erratum: Angiotensin II/AT2 receptor-induced vasodilation in SHRSP involves nitric oxide and cGMP-dependent protein kinase (Journal of Hypertension (2006) 24 (2417-2422)) (2007) (2)
Reactive Oxygen Species, Oxidative Stress, and Hypertension (2010) (2)
Hypertension 2022 Update: Focusing on the Future. (2022) (2)
Expression of Cell Cycle Proteins in Blood Vessels of Angiotensin II–Infused Rats (2001) (2)
Combination antihypertensive treatment with aliskiren and blockers of the Renin-Angiotensin system-reassurance but with a note of caution. (2013) (2)
A Woman With Treatment-Resistant Hypertension. (2016) (2)
Assessment of Caveolae/Lipid Rafts in Isolated Cells. (2017) (2)
Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy (2022) (2)
Cell Biology of Vessels (2019) (2)
Persistent Elevation of VEGF and Prostacyclin Following Poor Cardiopulmonary Adaptation to High Altitude (2009) (2)
Chemerin/ChemR23 system plays crucial role upon vascular insulin signaling in db/db mice (2016) (2)
Cancer Therapy-Related Hypertension: A Scientific Statement From the American Heart Association. (2023) (1)
Mas Signaling: Resolved and Unresolved Issues (2015) (1)
RESISTANCE ARTERIES IN TYPE 2 DIABETIC PATIENTS UNDER ANTIHYPERTENSIVE TREATMENT SHOW MARKED REMODELING.: P 460 (2004) (1)
LOCAL ENDOTHELIAL DNA REPAIR DEFICIENCY CAUSES AGING- (2020) (1)
The α1D-adrenoreceptor antagonist BMY 7378 reverses cardiac hypertrophy in spontaneously hypertensive rats. (2020) (1)
Resistant Hypertension: Trials and Tribulations (2018) (1)
Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage (2022) (1)
Liquorice alert (2009) (1)
Magnesium and vessels (2013) (1)
O-42: ANG II activates P38 MAP kinase and ERK1/2, but not JNK, in vascular smooth muscle cells from SHR (2001) (1)
UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: Questionnaire and workshop proceedings (2020) (1)
Time to fiddle with your unpublished data. (2021) (1)
Reply to letter by S. Bund regarding 'differential effects of vasopressin and endothelin-1 on vascular contractile and calcium responses in pressurized small arteries from SHR (1997) (1)
Abstract MP02: Angiotensin II Mediates Microvascular Rarefaction In Vivo and Exacerbates Endothelial-To-Mesenchymal Transition In Vitro (2015) (1)
A0996 Downregulated serum 14, 15-EET is associated with abdominal aortic calcification in patients with primary aldosteronism (2018) (1)
[The magnesium global network (MaGNet) to promote research on magnesium in diseases focusing on covid-19]. (2021) (1)
Ang II type 2 receptor activates JNK/SAPK-dependent signaling pathways. (1999) (1)
Arterial Hypertension in Women: State of the Art and Knowledge Gaps. (2023) (1)
Oxidative Stress, Inflammation, Immune System and Hypertension (2019) (1)
Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs. (2020) (1)
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study (2023) (1)
Selective Motion Artefact Reduction via Radiomics and k-space Reconstruction for Improving Perivascular Space Quantification in Brain Magnetic Resonance Imaging (2021) (1)
Chemiluminescence and the Nox1-Nox2-Nox4 Triple Knockout. (2015) (1)
Insulin-Induced Ca 2 + Transport Is Altered in Vascular Smooth Muscle Cells of Spontaneously Hypertensive Rats (2005) (1)
Anatomy and Pharmacology of Vessels (2019) (1)
P-338: Gender differences in blood pressure in estrogen-deficient FORKO mice (2002) (1)
POA 02-3 SMALL VESSEL DISEASE AND HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS. (2016) (1)
Response to European Society of Hypertension and European Society of Cardiology guidelines and the muted enthusiasm for home blood pressure monitoring. (2014) (1)
Response to European Society of Hypertension and European Society of Cardiology Guidelines and the Muted Enthusiasm for Home Blood Pressure Monitoring (2014) (1)
Tempol, Vitamin C and Vitamin E Improve Endothelial Dysfunction, Regress Vascular Hypertrophy and Prevent Progression of Hypertension and Renal Dysfunction in Stroke-Prone Shr (2000) (1)
CADASIL-CAUSING NOTCH3 MUTATION CONTRIBUTES TO THE DEVELOPMENT OF PULMONARY ARTERIAL HYPERTENSION IN MALES (2021) (1)
Abstract 010: Adipocyte-derived Aldosterone And Cortisol Are Nox1/4 Dependent: Implications In Obesity-associated Vascular Dysfunction. (2014) (1)
Report of the first International Society of Hypertension (ISH) Trainee/New Investigator Symposium: A Global Hypertension Initiative. (2012) (1)
Disturbed Mg++ transporters in hypertension (2008) (1)
Precision medicine in hypertension (2016) (1)
CONNed in Pregnancy. (2021) (1)
Palmitoylation regulates cellular distribution of and transmembrane Ca flux through TrpM7. (2022) (1)
NADPH Oxidase Nox5 Aggravates Renal Injury in Akita Mouse Model of Diabetic Nephropathy (2018) (1)
Aetiology of hypertension in blacks (1989) (1)
Attenuated Development of Hypertension by Antioxidant Vitamins in Stroke-Prone Shr Is Associated with Increased Vascular Superoxide Dismutase Activity and Decreased Oxidative Stress. (2000) (1)
Hypertension Education Program Recommendations What Are the New Messages ? (2006) (1)
Resistant Hypertension in a Dialysis Patient. (2020) (1)
Activators of AMP-activated protein kinase regulate adipocyte aldosterone secretion and mineralocorticoid receptor signalling (2015) (1)
Report of the International Society of Hypertension Teaching Seminar organized by the International Society of Hypertension Africa Regional Advisory Group: Maputo, Mozambique, 2016. (2016) (1)
170 Fetuin-a induces nox1-ros-dependent vascular dysfunction partially through toll like receptor 4 activation (2017) (1)
Measurement of phospholipase d activation in vascular smooth muscle cells. (2001) (1)
Woman With Polycystic Kidney Disease: The Role of Precision Medicine in Hypertension Management. (2020) (1)
41 Vascular protein oxidation and redox proteomics in human hypertension (2015) (1)
Magnesium responsiveness to angiotensin II and endothelin-1 in vascular smooth muscle cells from spontaneously hypertensive rats. (2001) (1)
Case of Primary Aldosteronism With Discordant Hormonal and Computed Tomographic Findings (2017) (1)
Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland. (2019) (1)
Microparticles and Exosomes in Cell-Cell Communication (2019) (1)
Cardiovascular-Kidney Interactions in Health and Disease Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats (2005) (1)
I012: AT1 receptor activation of vascular smooth muscle cell ERK1/2 and p38 map kinase is differentially regulated in genetic hypertension (2000) (1)
Transient Receptor Potential Melastatin 7 Cation Channel (TRPM7) Kinase: a new player in Ang II-induced hypertension (2016) (1)
Rationale and Design for the LOnger-term effects of SARS-CoV-2 INfection on blood Vessels And blood pRessure (LOCHINVAR): an observational phenotyping study (2022) (1)
Transient Receptor Potential Melastatin 7 Cation Channel (TRPM7) Kinase: a new player in Ang II-induced hypertension (2016) (1)
Progressive Hypertension and Severe Left Ventricular Outflow Tract Obstruction. (2019) (1)
A Message to the Hypertension Community Regarding the Ukraine Crisis. (2022) (1)
0096 : Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase (2015) (1)
159 Trpm2 ion channel activation contributes to redox-sensitive vascular dysfunction in hypertension (2017) (1)
Oxidase-Derived Reactive Oxygen Species Independently of Blood Pressure Elevation ? Inflammation and Vascular Hypertrophy Induced by Angiotensin II : Role of NADPH (2003) (1)
Vascular Biology of Magnesium: Implications in Cardiovascular Disease (2013) (1)
Case of Episodic and Positional Hypertension: Diagnosis and Treatment. (2020) (1)
Targeting the ailing endothelium – current concepts and future prospects (2008) (1)
Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity (2021) (1)
A9907 Cardiovascular inflammation and fibrosis in TRPM7-kinase deficient mice (2018) (1)
AMPK activators modulate pro-inflammatory responses in human adipocytes (2015) (1)
Exercise training protects against atherosclerotic risk factors through vascular NADPH oxidase , ERK 1 / 2 and SAPK / JNK down-regulation in obese rats (2014) (1)
P-203: H2O2 modulates calcium-dependent signaling pathways in vascular smooth muscle cells -alterations in SHR (2002) (1)
Hypoparathyroidism and recurrent hypomagnesaemia since infancy: a rare genetic cause (2017) (0)
Abstract P097: Molecular Mechanisms of VEGFR Inhibition-induced Endothelial Cell Damage (2015) (0)
PS-BPB01-6: PROTECTIVE NOX4 EFFECT IN ENDOTHELIAL CELLS INVOLVES ACTIVATION OF TRANSIENT RECEPTOR POTENTIAL MELASTATIN 2 (TRPM2) CATION CHANNEL (2023) (0)
PS 07-14 VASCULAR PROTEIN OXIDATION AND REDOX PROTEOMICS IN HYPERTENSION (2016) (0)
Testosterone modulates mitochondria activity and induces expression of apoptotic markers in Wistar-Kyoto VSMC (2008) (0)
Abstract 33: Atorvastatin Downregulates Vascular Nox Expression and Ameliorates Oxidative Stress-associated Inflammatory Process in Type 2 Diabetic Db/db Mice (2013) (0)
Hypertension, alcohol and black and coloured South (1989) (0)
IMMUNE DYSREGULATION INDUCED BY SPIKE PROTEIN 1 OF SARS-COV-2 INCREASES ENDOTHELIAL CELL DYSFUNCTION VIA TYPE I AND TYPE III INTERFERON ACTIVATION PATHWAYS (2022) (0)
A10274 Interplay between Nox-regulated oxidative stress and ER stress response in experimental hypertension (2018) (0)
Abstract 373: Mineralocorticoid Receptor and Rhoa/rho Kinase Contribute to Vascular Dysfunction in Obese Db/db Mice (2013) (0)
Final Version Differential Regulation of Transient Receptor Potential Melastatin 6 and 7 (TRPM6/7) Cation Channels by Angiotensin II in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats (2005) (0)
OS 21-03 EFFECTS OF THE TRPM7 KINASE DOMAIN IN VASCULAR DYSFUNCTION AND CARDIAC FIBROSIS INDUCED BY ALDOSTERONE AND SALT. (2016) (0)
ONLINE DATA SUPPLEMENT Nox1, Nox4 and Nox5, promote vascular permeability and neovascularization in retinopathy (2020) (0)
Abstract 1626: Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Inflammatory Biomarkers in Hypertensive Patients (2007) (0)
Abstract 367: A Nox4 Inhibitor, GKT 137831, Decreases Aldosterone Synthesis, Adiposity and Vascular Contractility in a Murine Model of Diabetes. (2012) (0)
Abstract 058: High Sodium Intake Induces a Catabolic State via Glomerular Hyperfiltration and Enhanced Glomerulotubular Balance in Essential Hypertension (2019) (0)
Hypertension and oxidant stress (2004) (0)
EPLERENONE PREVENTS CARDIAC AND VASCULAR REMODELING AND IMPROVES RENAL FUNCTION IN SALT-DEPENDENT HYPERTENSION: P 225 (2004) (0)
A Role for Rho-Associated Kinase in Aberrant Pulmonary Vascular Reactivity in a Mouse Model of Cerebral Autosomal Dominant Subcortical Infarcts and Leukoencephalopathy (CADASIL) (2019) (0)
Abstract 4: Transient Receptor Potential Melastatin 7 Cation Channel (TRPM7) Kinase Domain - a New Player in Angiotensin II-induced Hypertension and Cardiac Hypertrophy (2013) (0)
Abstract 282: 17β-Estradiol and 16α-Hydroxyestrone Increase Oxidative Stress Through Nrf2 Dysfunction In Human Pulmonary Artery Smooth Muscle Cells - Implications in Pulmonary Hypertension. (2014) (0)
370 Increase Inflammation, Oxidative Stress and Basal Peripheral Arterial Blood Flow in Ambulatory Patients Suffering from Heart Failure With Preserved Ejection Fraction (2012) (0)
c-Src regulates vascular inflammatory and fibrogenic but not growth signaling pathways in aldosterone-induced hypertension (2007) (0)
Abstract 017: Ang-(1-7) Influences ET-1 Signaling Through MAS: ETBR Interactions: Implications in Pulmonary Hypertension (2015) (0)
P4919Serotonin signaling through the 5-HT1B receptor and NADPH oxidase 1 in pulmonary arterial hypertension (2017) (0)
3 Angiotensin 1–7 regulation of endothelin-1 system in pulmonary hypertension (2015) (0)
A10228 Endothelial microparticles from vegf inhibitor (vegfi)-treated cancer patients mediates endothelial cell signaling and et-1 production: implications in vegfi-induced hypertension (2018) (0)
127Prevalence of coronary artery disease and coronary microvascular dysfunction in heart failure with preserved ejection fraction (2019) (0)
Abstract 151: Mineralocorticoid Receptor Antagonism Prevents Vascular Remodeling in Mesenteric Arteries of Mice with type 2 Diabetes (2013) (0)
Abstract 279: Vascular Aging In Aldosterone Associated Hypertension: Role Of NADPH Oxidase 1 (2014) (0)
S-07-4: VASCULAR SMOOTH MUSCLE CELL PROTEOME AND PHENOTYPIC SWITCHING IN HUMAN HYPERTENSION ARE NOX5-DEPENDENT (2023) (0)
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study (2023) (0)
Abstract P109: Angiotensin-(1-9) Reverses Cardiac Dysfunction in a Model of Angiotensin II-Induced Hypertensive Heart Disease by Acting as a Positive Inotrope (2015) (0)
Increased Generation of Vascular Reactive Oxygen Species by Ang II Is Mediated Via Src-Dependent Pathways in Essential Hypertension. (2000) (0)
Abstract P217: Nox Compartmentalization, Protein Oxidation and ER Stress in Vascular Smooth Muscle Cells in Hypertension (2017) (0)
Hypertension and renal failure prevention and management after cancer therapy (0)
Abstract MP31: Peripheral Vascular Dysfunction In A Model Of Small Vessel Disease Of The Brain (CADASIL) Involves Impaired Redox-sensitive Cyclic GMP/PKG Signaling (2020) (0)
Abstract P228: Protective Role of TRPM7-kinase Against Vascular Dysfunction and Fibrosis Induced by Aldosterone and Salt (2016) (0)
Abstract 263: Differential Effects of 17ß-Estradiol and 16a-Hydroxyestrone in Oxidative Stress and Proliferative Responses in Human Pulmonary Artery Smooth Muscle Cells - Implications in Pulmonary Arterial Hypertension (2013) (0)
Abstract 36: High Salt Induces Vascular Damage Through Redox-sensitive Parp/trpm2-induced Calcium Influx And Inflammasome Modulation Without Influencing Blood Pressure (2021) (0)
Renal biomarkers: novel surrogates of small and large vessel disease? (2011) (0)
OR-22: Src is an upstream regulator of NADPH oxidase in human vascular smooth muscle cells (2002) (0)
Abstract 218: TRPM7 Kinase - A Novel Signaling Pathway for Ang II-induced MAPK Activation in Vascular Smooth Muscle Cells. (2012) (0)
Vascular Biology of Cancer Chemotherapeutic Drugs (2019) (0)
PROTEOMIC PROFILE OF CYSTEINE OXIDATION IN VASCULAR SMOOTH MUSCLE CELLS IN HUMAN HYPERTENSION (2022) (0)
Clinical Science: showcasing the breadth of the journal. (2017) (0)
136Rates, risks and routes to reduce vascular dementia (R4VAD) (2019) (0)
ISH PRE-2 THE VASCULAR PHENOTYPE IN HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS. (2016) (0)
NOX5 AND VASCULAR SIGNALLING IN HUMAN HYPERTENSION (2021) (0)
Faculty Opinions recommendation of Effect of regular phosphodiesterase type 5 inhibition in hypertension. (2006) (0)
P-438: Mitogen-activated protein (MAP) kinase signaling through calcineurin-dependent pathways in cardiac fibroblasts (2005) (0)
Abstract 101: Chemerin, A Novel Adipokine, Regulates Human Vascular Cell Function Through Redox-sensitive Processes Involving NADPH Oxidase 1/4 And Endothelial Nitric Oxide Sinthase. (2014) (0)
Abstract 020: Nox5 Regulates Vascular Smooth Muscle Cell De-differentiation In Human Hypertension (2022) (0)
Abstract 372: Role of Redox-Sensitive Calcium Channel TRPM2 and Oxidative Stress in Vascular Smooth Muscle Cell Differentiation to an Osteogenic Phenotype: Implications in Hypertension. (2012) (0)
Ang-(1-7) non-peptide mimetic (AVE0991) prevents atherogenesis in ApoE-/- mice by inhibiting perivascular macrophage infiltration and activation (2015) (0)
Abstract 089: Role of Nox5 in Systemic Vascular Dysfunction in Ischemic Heart Disease (2019) (0)
Montezano and Touyz Ang II , Aldosterone , and the Heart 1017 (2008) (0)
CHARACTERIZATION OF A NEW MURINE TRANSGENIC MODEL OF ENDOTHELIAL CELL HUMAN ENDOTHELIN-1 OVEREXPRESSION.4: P 062 (2004) (0)
Abstract 316: Angiotensin 1-7 Regulation Of Endothelin-1 System In Pulmonary Arterial Hypertension (2014) (0)
Abstract P145: Notch3 Mutation is Involved in Pulmonary Vascular Dysfunction and Development of Pulmonary Arterial Hypertension (2019) (0)
Faculty Opinions recommendation of Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. (2012) (0)
Protein disulfide isomerase regulation of Nox1 contributes to vascular dysfunction in hypertension (2022) (0)
14 EMERGING VASCULAR TARGETS: MICROPARTICLES A NEW PLAYER IN VASCULAR SIGNALING (2012) (0)
A9595 Crosstalk Between Vascular Redox and Calcium Signalling in Hypertension Involves Transient Receptor Potential Melastatin 2 Channel Activation (2018) (0)
Vascular Endothelial Growth Factor (VEGF) inhibitors as a novel strategy in the treatment of Arterio Venous Malformations (AVMs): time for a clinical study (2014) (0)
Abstract MP08: Syndecan-1 is Involved in Osteoprotegerin-induced Vascular Dysfunction (2015) (0)
Abstract P071: Mineralocorticoid Receptor Overexpression in Adipose Tissue Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase PTGDS and lipocalin-2 NGAL (2015) (0)
Glasgow Magnesium Symposium 2022: Wrap up and depart (2022) (0)
Fibrosis in Mineralocorticoid-Dependent Hypertension Activators Prevent Cardiac γ and Receptor-α Peroxisome Proliferator-Activated Receptor (2003) (0)
ANGIOTENSIN II-INDUCED AT2 STIMULATION NEGATIVELY MODULATES RHO KINASE-DEPENDENT PHOSPHORYLATION OF MYOSIN LIGHT CHAIN IN VASCULAR SMOOTH MUSCLE CELLS AND PROMOTES VASORELAXATION IN SHRSP RESISTANCE ARTERIES: OP 076 (2004) (0)
Abstract P197: TRPM7 is Involved in the Effects of VEGF and EGF in Vascular Cells (2019) (0)
Angiotensin II activation of Src mediates ERK stimulation in human vascular smooth muscle cells (1999) (0)
Abstract 491: Nox4 Inhibition, by GKT 137831, Decreases Obesity-Associated Vascular Dysfunction and Pro-Fibrotic Effects (2013) (0)
Faculty Opinions recommendation of Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. (2008) (0)
LB03.07: ANTIHYPERTENSIVE THERAPY AND RISK OF ADMISSIONS FOR MOOD DISORDERS (2015) (0)
Lifestyle and BP: making a healthy change (2007) (0)
Accelerated vascular aging in aldosterone associated hypertension: role of NADPH oxidase 1 and implications for cardiovascular complications (2015) (0)
INTERACTION BETWEEN TRPM7 AND EPIDERMAL GROWTH FACTOR RECEPTOR MEDIATES VASCULAR SMOOTH MUSCLE CELL ACTIVATION AND PROLIFERATION (2021) (0)
Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction (2021) (0)
B003: Pld-dependent generation of oxygen species is increased in ang ii-stimulated vascular smooth muscle cells from hypertensive patients (2000) (0)
Chapter 10 – Cardiovascular Complications from Cancer Therapy: Hypertension–Focus on Vascular Endothelial Growth Factor Inhibitors (2016) (0)
Stroke-Prone Spontaneously Hypertensive Rats Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Fibrosis in (2004) (0)
ENHANCING INTERACTIONS BETWEEN MASR AND ETBR AS A NEW VASOPROTECTIVE STRATEGY (2021) (0)
Abstract 049: Endothelial-Derived Microparticles as Biomarkers and Mediators of Endothelial Cell Injury in VEGF Inhibitor-Treated Cancer Patients: Implications in Hypertension (2018) (0)
Improved Renal Function by Eta Receptor Blockade Is Associated with Reduced Renal Expression of Tgfβ and B FGF and Increased Activity of Mmp-2 in Shrsp (2000) (0)
Abstract 011: TRPM7 is Cardiovascular Protective in Aldosterone-Induced Hypertension (2019) (0)
INHIBITION OF ACE C-DOMAIN AND NEPRILYSIN AS A NEW THERAPY IN HYPERTENSION (2021) (0)
TRPV4 Channel-Regulated Microdomains Define a New Paradigm in Hypertension. (2022) (0)
Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. (2023) (0)
Abnormalities of the lymphatic system and impaired fluid clearance in patients with heart failure with preserved ejection fraction (2020) (0)
Abstract 56: Proteome Profile Of Vascular Smooth Muscle Cells During Phenotypic Switching In Human Hypertension (2021) (0)
Abstract 014: Nox1-derived ROS Impairs Internal Pudendal Artery Function via Nrf2 and Rho Kinase in Diabetic Mice (2015) (0)
Hope for resistant hypertension through BrigHTN and PRECISION (2023) (0)
Magnesium supplementation attenuates aldosterone‐induced hypertension, kidney damage and oxidative stress in genetically hypomagnesemic mice (2010) (0)
[PS 01-14] SYNDECAN-1 IS INVOLVED IN OSTEOPROTEGERIN-INDUCED REACTIVE OXYGEN SPECIES PRODUCTION AND VASCULAR INJURY (2016) (0)
A10817 Nox5 regulation of vascular contraction involves oxidation of endoplasmic reticulum calcium channels and calreticulin (2018) (0)
Faculty Opinions recommendation of Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. (2009) (0)
PPAR&agr; Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation (2002) (0)
Abstract P085: Microrna Profiling Of Vascular Smooth Muscle Cells In Human Hypertension Potential Regulators Of Endoplasmic Reticulum And Oxidative Stress (2020) (0)
Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension (2022) (0)
A12666 Nox4 deficiency leads to hypertension and vascular damage with enhanced effects in Ang II-dependent hypertension (2018) (0)
Acid-Induced Chloride Current in Distal Convoluted Tubule (2016) (0)
Mineralocorticoid Receptor and Rhoa/rho Kinase Contribute to Vascular Dysfunction in Obese Db/db Mice (2013) (0)
OS 02-01 ROLE OF ALDOSTERONE AND NADPH OXIDASE 1 IN HYPERTENSION-ASSOCIATED VASCULAR AGING (2016) (0)
VASCULAR EFFECTS OF ANTI-CANCER CISPLATIN THERAPY (2018) (0)
OS 02-01 ROLE OF ALDOSTERONE AND NADPH OXIDASE 1 IN HYPERTENSION-ASSOCIATED VASCULAR AGING. (2016) (0)
195 Angiotensin-(1-9) Reduces Cardiac Dysfunction in a Model of Angiotensin II-Induced Hypertensive Heart Disease (2015) (0)
[PP.03.16] INCREASED ROS GENERATION INVOLVES MITOCHONDRIA IN MR-OVEREXPRESSING ADIPOCYTES – IMPACT ON VASCULAR FUNCTION. (2016) (0)
P-343: Aldosterone activates ERK1/2 and p38map kinase in vascular smooth muscle cells by nongenomic mechanisms in WKY and SHR – role of endothelin-1 (2004) (0)
Abstract 372: Upregulation of the Mineralocorticoid System in Obesity-associated Diabetes Leads to Increased Adipocyte Rho Kinase Activation and Dysregulation of Adipocytokines (2013) (0)
50 Ischaemia and No Obstructive Coronary Artery Disease (INOCA): prevalence and predictors of coronary vasomotion disorders (2019) (0)
PS-B01-12: SEXUAL DIMORPHISM OF CEREBROVASCULAR NOX5-NOTCH3 SIGNALLING IN ANGIOTENSIN II-INDUCED HYPERTENSION (2023) (0)
Abstract MP48: EGF Regulates VSMC Migration And Proliferation Through Crosstalk Between TRPM7 And EGFR (2020) (0)
Rare Disease Leading to Hypertension. (2022) (0)
Abstract P262: Spike Protein 1 Of Sars-cov-2 Increases Interferon Stimulated Genes And Induces An Immune/inflammatory Responses In Human Endothelial Cells. (2021) (0)
F012: Antioxidant treatment reverses vascular remodeling, but not myogenic tone in mesenteric resistance arteries of stroke-prone spontaneously hypertensive rats (SHRSP) (2000) (0)
MAGNESIUM NEGATIVELY REGULATES RHOA/RHO KINASE-DEPENDENT SIGNALING AND CONTRACTION IN VASCULAR SMOOTH MUSCLE CELLS-IMPLICATIONS IN HYPERTENSION Rhian Touyz: P 245 (2004) (0)
Magnesium responsiveness to Ang II and ET-1 in vascular smooth muscle cells from spontaneously hypertensive rats (2001) (0)
Abstract 571: Osteogenic Factors Regulate Vascular Function Through Reactive Oxygen Species And Toll-Like Receptor 4 Activation: Role In Hypertension. (2014) (0)
Abstract 009: CETP inhibitors Torcetrapib, Dalcetrapib, and Anacetrapib induce adipocyte-derived Aldosterone production through Nox and STAT3 activation (2014) (0)
Biomarkers of hypertension and cardiovascular disease (2015) (0)
OS 21-03 EFFECTS OF THE TRPM7 KINASE DOMAIN IN VASCULAR DYSFUNCTION AND CARDIAC FIBROSIS INDUCED BY ALDOSTERONE AND SALT (2016) (0)
Altered vascular function in boys with hypospadias- role of reactive oxygen species (2018) (0)
224 Vascular endothelial growth factor receptor inhibition induces vascular dysfunction via redox-sensitive processes (2017) (0)
Borderline and Hypertension. (2021) (0)
Abstract 74: The Nox4 Inhibitor GKT137831, Prevents Aldosterone Production by Adipocytes and Protects Against Adipose Tissue Inflammation and Fibrosis in Obese Mice (2013) (0)
Edinburgh Research Explorer Examining the relationship between semiquantitative methods analysing concentration-time and enhancement-time curves from dynamic-contrast enhanced magnetic resonance imaging and cerebrovascular dysfunction in small vessel disease (2020) (0)
Expression of Cell Cycle Proteins P21waf1/Cip1, P27kip1, Cyclin D1 and CDK4 in Blood Vessels of Angiotensin II-Infused Rats. Role of AT1 Receptors. (2000) (0)
OP10 Skin Na+ excess in hypertensive patients: isotonic nature and clinical correlates (2020) (0)
Mg2+ Channels as the Link Between Mg2+ Deficiency and COMT Downregulation in Salt-Sensitive Hypertension. (2021) (0)
Abstract 099: Fetuin-A and Toll-like Receptor 4 Regulate Vascular Function: Role of Nox1 (2015) (0)
Ca 2+ dependent-NOX5 exaggerates cardiac hypertrophy through ROS production (2021) (0)
Oxidative stress in arterial hypertension and atherosclerosis (2011) (0)
Abstract MP10: Early Functional and Structural Alterations of Resistance Arteries in Mice Treated with an Inhibitor of the Vascular Endothelial Growth Factor Receptor (2014) (0)
Protein Tyrosine Phosphatase Type 1B (PTP1B) Contributes To Atherosclerotic Processes By Mechanisms That Involve NADPH‐Oxidase And Calcium Influx (2020) (0)
Abstract T5: Molecular Mechanisms Involved In The Vascular Protective Effects Of Mas1 And Et B R Interaction (2021) (0)
OS 15-08 Ang(1-7) INFLUENCES ET-1 SIGNALING THROUGH MAS: ETBR INTERACTIONS: IMPLICATIONS IN PULMONARY HYPERTENSION. (2016) (0)
SUN-551 Impaired Vascular Relaxation and Altered eNOS Regulation in Boys with Hypospadias (2020) (0)
Abstract 630: Differential Renal And Cardiac Effects Of Nox4 In Chronic Angiotensin II-Dependent Hypertension (2014) (0)
Ang II-induced proto-oncogene expression is altered in vascular smooth muscle cells from essential hypertensive patients — implications in vascular remodeling. (1999) (0)
Hypertension With Negative Metaiodobenzylguanidine Scintigraphy. (2021) (0)
TRPM7 IS PROTECTIVE AGAINST CARDIOVASCULAR DAMAGE INDUCED BY ALDOSTERONE AND SALT (2021) (0)
IMPAIRED NO SIGNALLING, ER STRESS AND RHO KINASE MEDIATE PERIPHERAL VASCULAR DYSFUNCTION IN A MODEL OF SMALL VESSEL DISEASE OF THE BRAIN (CADASIL) (2021) (0)
ON LINE SUPPLEMENT ALLOPURINOL INITIATION AND CHANGE IN BLOOD PRESSURE IN OLDER ADULTS WITH HYPERTENSION Authors (0)
Callera et al Endothelin and Oxidative Stress in DOCA-Salt Rats 813 (2003) (0)
Vascular Signaling (2019) (0)
Aldosterone regulates the TRPM7 chanzyme (2012) (0)
Blood Vessels (2019) (0)
Reactive Oxygen Species, Vascular Disease, and Hypertension 47 (2014) (0)
Response to Are the Eutrophic Effects of Angiotensin Receptor Blockers Real (2006) (0)
1II roentgenogram ofthemonth Hypoglycemia Associated with a Lung Mass (2017) (0)
Acute ethanol intake induces mitogen-activated protein kinase activation, platelet-derived growth factor receptor phosphorylation, and oxidative stress in resistance arteries (2014) (0)
TRPM7 deficiency exacerbates cardiovascular and renal damage induced by aldosterone-salt (2022) (0)
MODULATION OF ENDOTHELIAL FUNCTION TO PRODUCE CARDIO-AND RENO-PROTECTION IN HYPERTENSIVE CHRONIC KIDNEY DISEASE PATIENTS (2012) (0)
Measurement of intracellular free calcium ion concentration in vascular smooth muscle cells : fluorescence imaging of cytosolic calcium. (2000) (0)
The renin angiotensin system (RAS) in the heart: Effects of aerobic training (2016) (0)
Normal serum magnesium values and the diagnosis of magnesium deficiency. (1989) (0)
Testosterone-induced Leukocyte Migration Involves COX2 and Redox-Sensitive Processes in rats (2010) (0)
Changes in Plasma Biomarkers of Inflammation, Oxidative Stress and Thrombosis Following De Novo Cardiac Transplantation: Effects of Immunosuppressive Therapy (2010) (0)
ROLE OF VASCULAR NOX5 IN ANG II-MEDIATED PRO-FIBROTIC AND PRO-INFLAMMATORY SIGNALLING IN THE KIDNEY (2021) (0)
Chapter 99 – Arterial Hypertension (2012) (0)
Nox5 in Vascular Smooth Muscle Cells Mediates Ang II‐Induced Renal Fibrosis and Inflammation (2021) (0)
NADPH oxidase, NOX1, is a key source of oxidative stress in retinopathy and neovascularization (2013) (0)
MICRORNA PROFILE IN HUMAN VASCULAR SMOOTH MUSCLE CELLS FROM HYPERTENSIVE SUBJECTS: FOCUS ON OXIDATIVE AND ENDOPLASMIC RETICULUM STRESS (2021) (0)
Abstract 092: Tissue Sodium is a Highly Sensitive Marker of Subclinical and Localised Edema (2018) (0)
Abstract 277: Nox Isoforms, Oxidative Stress, Inflammation And Fibrosis In Adipose Tissue In Obese Mice: Differential Regulation In Epididymal, Perirenal And Perivascular Depots. (2014) (0)
Abstract 129: TRPM7 α-kinase Deficiency Causes Cardiovascular Inflammation and Fibrosis. (2018) (0)
What Do We Know About the Need for Revascularization in Patients With an Asymptomatic Carotid Stenosis ? (2017) (0)
Abstract 138: Altered Vascular Reactivity in Mice Overexpressing Adipocyte Mineralocorticoid Receptors - Role of Rho Kinase. (2012) (0)
Vascular dysfunction and increased cardiovascular risk in hypospadias (2022) (0)
Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19 (2023) (0)
Model of Menopause-Associated Hypertension Attenuated Responses to Angiotensin II in Follitropin Receptor Knockout Mice, a (2010) (0)
Expanding the phenotypic spectrum of Kenny-Caffey syndrome: a case series and systematic literature review. (2023) (0)
Chapter 7:Biomarkers of Hypertension and Cardiovascular Disease (2015) (0)
[PP.22.23] VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR INHIBITION INDUCES VASCULAR DYSFUNCTION VIA REDOX-SENSITIVE AND NITRIC OXIDE-DEPENDENT PATHWAYS (2017) (0)
Vascular Nox compartmentalization, protein hyperoxidation and ER stress response in hypertension (2018) (0)
Abstract P153: Crosstalk Between Vascular Redox and Calcium Signalling in Hypertension Involves Transient Receptor Potential Melastatin 2 (TRPM2) Channel (2018) (0)
Examining the Relationship between Semiquantitative Methods Analysing Concentration-Time and Enhancement-Time Curves from Dynamic-Contrast Enhanced Magnetic Resonance Imaging and Cerebrovascular Dysfunction in Small Vessel Disease (2020) (0)
Disturbed Mg++ transporters in hypertension. Authors' reply (2008) (0)
Some cellular events in hypertension - an overview (1990) (0)
PS-B01-7: VASCULAR SMOOTH MUSCLE CELL NOX5 REGULATES FIBROBLAST PHENOTYPIC SWITCH AND CARDIOVASCULAR FIBROSIS (2023) (0)
NOX5 EXPRESSION IN A VASCULAR SMOOTH MUSCLE CELL-SPECIFIC MANNER INDUCES FIBROBLAST PHENOTYPIC SWITCH AND PRO-FIBROTIC EFFECTS (2022) (0)
Reply to Letter by McIntyre et al. (2014) (0)
Faculty Opinions recommendation of Genome-wide association study of blood pressure and hypertension. (2009) (0)
A multisystem, cardio-renal investigation of post-COVID-19 illness (2022) (0)
Abstract P3002: Endoplasmic Reticulum Stress Plays a Role in Nox5 Mediated Vascular Contraction (2019) (0)
Abstract P073: Chemerin Receptor Antagonism Improves Vascular Insulin Signaling in Diabetic Mice (2015) (0)
Abstract 44: VEGF Inhibitor-induced Vascular Dysfunction Is Ameliorated By PARP/TRPM2 Inhibition (2021) (0)
The Serotonin Transporter Promotes a Pathological Estrogen Metabolic Pathway in Pulmonary Hypertension via Cytochrome P 450 1 B 1 Running title : Serotonin transporter , estrogen , CYP 1 B 1 and pulmonary hypertension (2015) (0)
Cardiovascular Oncologic Emergencies (2021) (0)
Antioxidant vitamins inhibit progression of hypertension and improve endothelial dysfunction and antioxidant status in SHRSP (2000) (0)
OPINION New insights into mechanisms of hypertension (2012) (0)
University of Dundee UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment McFall, (2020) (0)
Patients Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive (2007) (0)
Spike protein 1 of SARS‐CoV‐2 induces an immune and inflammatory response and increases expression of ACE2 in human endothelial cells (2021) (0)
Abstract 040: Vascular Dysfunction and Androgen Deficiency - Insights From Children With Hypospadias (2018) (0)
Circulation: Cardiovascular Interventions. (2016) (0)
PMON312 A De Novo Heterozygous Nonsense Variant In The SEC31A Gene Associated With Pituitary Hormone Deficiency And Disorders Of Sex Development. (2022) (0)
TISSUE NA+ EXCESS UPON EXPERIMENTAL SALT-LOADING IS SYSTEMIC AND REFLECTS ISOTONIC OEDEMA (2021) (0)
Role of PARP and TRPM2 in VEGF Inhibitor-Induced Vascular Dysfunction. (2023) (0)
A1146 Aldosterone facilitates high phosphate-induced vascular calcification via upregulation of osteogenic factors (2018) (0)
B004: Upregulation of src plays an important role in altered vascular function in genetic hypertension (2000) (0)
Enhancing the Interaction Between MAS and ETB Receptors is Vasoprotective (2021) (0)
Cross-Talk Between Mineralocorticoid and Angiotensin II Signaling for Cardiac Remodeling. Commentary (2008) (0)
c-Src inhibition improves cardiovascular function but not remodeling or fibrosis in Ang II-induced hypertension (2016) (0)
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls (2023) (0)
INTRACELLULAR CALCIUM MOBILIZATION BY ANGIOTENSIN IV IN PRESENCE OF ANGIOTENSIN II IS AT1-DEPENDEN: SUGGESTING AN ALLOSTERIC MECHANISM OF AT1 ACTIVATION BY ANGIOTENSIN IV (2004) (0)
212 Cell membrane adenosine triphosphatases and cellular cation content in normotensive and hypertensive blacks and whites (1993) (0)
Abstract P092: Palmitoylation Controls Cell Surface Abundance Of Trpm7 (2020) (0)
Increased ROS generation involves mitochondria in MR-overexpressing adipocytes – impact on vascular function (2017) (0)
Reply to “Recommendation on an updated standardization of serum magnesium reference ranges,” Jeroen H.F. de Baaij et al. (2022) (0)
Abstract 510: Altered c-Src Activity by Aldosterone in Vascular Smooth Muscle Cells From SHR Involves PDGFR, C-terminal Src Kinase (Csk) and Csk-binding Protein (CBP). (2012) (0)
Abstract P153: Impact of Antibiotic Treatment on Antihypertensive Drug Adherence (2015) (0)
Abstract 614: Anti-inflammatory Effect of Ang-(1-7) non-peptide mimetic (AVE 0991), on T Cell Infiltration in Perivascular Adipose Tissue in ApoE-/- Mice (2014) (0)
Hypertension, diabetes and blood pressure targets: ongoing challenges (2016) (0)
P-331: Inhibition of the Na+/Mg2+ exchanger decreases blood pressure and modulates vascular ERK1/2 and p38 MAP kinase phosphorylation in Ang II-induced hypertensive rats (2002) (0)
ISH PRE-2 THE VASCULAR PHENOTYPE IN HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS. (2016) (0)
TEMPORAL CHANGES IN CARDIAC MOLECULAR EVENTS AND BIOMARKERS FOLLOWING DE NOVO CARDIAC TRANSPLANTATION (2011) (0)
Clinical Science: translating molecular bioscience and experimental research into medical insights. (2020) (0)
Faculty Opinions recommendation of Serum uric acid is associated with microalbuminuria in prehypertension. (2006) (0)
Hypertension and renal disease during anti-cancer therapies (0)
Response to the letter regarding the hypothesis paper "Much ado about N…atrium: modelling tissue sodium as a highly sensitive marker of subclinical and localised oedema". (2019) (0)
TRPM7 is protective against hypertension, cardiovascular inflammation and fibrosis induced by aldosterone and salt (2021) (0)
The α 1D -adrenoreceptor antagonist cardiac hypertrophy in spontaneously hypertensive rats. Short tittle: Effect of BMY 7378 on Myocardial Remodeling (2020) (0)
181 Nox compartmentalization and protein oxidation in vascular smooth muscle cells – implications in vascular dysfunction in hypertension (2017) (0)
Abstract 383: Candesartan, in a Dose-Related Manner, Upregulates the Protective Axis of the Renal Renin Angiotensin System and Prevents Progression of Diabetic Nephropathy in db/db Mice. (2012) (0)
S-07-7: ANGIOTENSIN, VASCULAR AGING AND HYPERTENSION (2023) (0)
[PP.LB01.07] IMPACT OF THE NICE/BHS GUIDELINES ON SPECIALIST HYPERTENSION CLINIC SERVICE (2016) (0)
Faculty Opinions recommendation of Strict blood-pressure control and progression of renal failure in children. (2010) (0)
7th Int. Symposium on Resistance Arteries (2004) (0)
Clinical Science-linking basic science to disease mechanisms. (2017) (0)
ACE2 and Proinflammatory Signaling by S1 Protein of SARS‐Cov‐2 in Human Endothelial Cells (2021) (0)
A030: Angiotensin II-activated map kinase pathways are associated with sustained vascular smooth muscle contraction (1998) (0)
Abstract P3005: P66shc Plays a Role in Aldosterone Induced Vascular Remodeling and Dysfunction (2019) (0)
Antihypertensive Drugs and Vascular Health (2018) (0)
S-18-4: ACE2 IS INVOLVED IN SARS-COV-2 INDUCED ENDOTHELIAL CELL INFLAMMATION INDEPENDENT OF VIRAL REPLICATION (2023) (0)
Expanding the phenotypic spectrum of Kenny-Caffey syndrome: a case series and systematic literature review. (2023) (0)
Faculty Opinions recommendation of Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. (2009) (0)
Connecting Generations of Scientists in the Council on Hypertension Through Harriet Dustan. (2021) (0)
Abstract P090: Nox5 Induces Vascular Damage Through C-src Activation In Human Hypertension (2020) (0)
POA 02-3 SMALL VESSEL DISEASE AND HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS. (2016) (0)
WK04 Three New Polymorphisms in the Promoter of Human Angiotensinogen Gene that Explain the Association of 6A Allele with Hypertension (2010) (0)
NOX4 PROTECTIVE EFFECT IN ENDOTHELIAL FUNCTION INVOLVES ACTIVATION OF TRANSIENT RECEPTOR POTENTIAL MELASTATIN 2 (TRPM2) CATION CHANNEL (2021) (0)
Abstract P083: Gender Specific Effects in Nox4-/- Mice in Hypoxia Induced Pulmonary Hypertension and Pulmonary Vascular Resistance (2015) (0)
Abstract 40: SARS-CoV-2/ACE2 Induces Vascular Inflammatory Responses In Human Microvascular Endothelial Cells Independently Of Viral Replication (2021) (0)
SKIN NA+ EXCESS IN HYPERTENSIVE PATIENTS: ISOTONIC NATURE AND CLINICAL CORRELATES (2021) (0)
Magnesium calcium sodium and potassium status in normotensive and hypertensive johannesburg south africa black patients (1984) (0)
Accelerated Atherosclerosis − NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus (2013) (0)
Persistent Elevation of Vascular Endothelial Growth Factor and Prostacyclin Following Cardiopulmonary Maladaptation to High Altitude: A Pilot study (2007) (0)
10.14 Peroxisome Proliferator-Activated Receptors Activator, Rosiglitazone, Improves Vascular Structure and Reduces Lipid Deposition in Atherosclerotic Mthfr Knock-Out Mice (2007) (0)
B005: Pi3 kinase regulates ang ii-stimulated erk activity in vascular smooth muscle cells from shr (2000) (0)
Abstract P510: Nox4 Deficiency Leads to Hypertension and Vascular Damage With Enhanced Effects in Ang II-dependent Hypertension (2017) (0)
Angiotensin II-induced vascular hypertrophy: involvement of B1-Kinin Receptor (2011) (0)
A systems biology approach for the sphingosine-1-phosphate signal transduction in vascular smooth muscle cell (2008) (0)
Abstract 488: Atorvastatin Inhibits Src/ROS-mediated Redox Sensitive And Pro-Inflammatory Actions of Aldosterone in Vascular Smooth Muscle Cells: Focus on Statins Pleiotropic Effects (2013) (0)
32 Premature vascular ageing in hypertension: role of aldosterone and nadph oxidases (2015) (0)
23 NADPH OXIDASE 5 (NOX5), cholesterol-rich microdomains and ANG II signallingsignaling in human primary vascular smooth muscle cells (1997) (0)
Phenotype-Specific Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells to Model Vascular Disease: Implications of Differentiation Protocols. (2023) (0)
35 Fetuin-A and toll-like receptor 4 regulate vascular function: role of Nox1 (2015) (0)
A10215 Altered vascular function in boys with hypospadias- role of reactive oxygen species (2018) (0)
Abstract 068: Interplay Between Nox5 and Endoplasmic Reticulum Stress Regulates Vascular Signalling in Human Hypertension (2019) (0)
39 Molecular mechanisms of VEGFR inhibition-induced endothelial cell damage (2015) (0)
LB02.06: CLINICAL IMPLICATIONS OF THE DIASTOLIC BLOOD PRESSURE ‘J CURVE’ IN TREATED HYPERTENSIVE PATIENTS (2015) (0)
The impact of reporting magnetic resonance imaging incidental findings in the Canadian alliance for healthy hearts and minds cohort (2021) (0)
Hypertension: Methods and Protocols (2017) (0)
OS 15-08 Ang(1–7) INFLUENCES ET-1 SIGNALING THROUGH MAS: ETBR INTERACTIONS IMPLICATIONS IN PULMONARY HYPERTENSION (2016) (0)
Nad(p)h Oxidase Regulates Cyclin D1 and Cdk4 but not P21Cip1 and P27Kip1 - Role in Ang Ii-mediated Growth of Human Vsmcs: P48 (2005) (0)
Molecular mechanisms associated to reversion of proteinuria by RAS antagonists in renovascular hypertensive rats (1088.4) (2014) (0)
ENDOTHELIN-1 REGULATES MAP KINASES THROUGH MITOCHONDRIAL-DERIVED REACTIVE OXYGEN SPECIES, WHEREAS ANGIOTENSIN II EFFECTS ARE MEDIATED VIA NADPH OXIDASE-DERIVED SUPEROXIDE IN HUMAN VASCULAR SMOOTH MUSCLE CELLS: OP 104 (2004) (0)
ANGIOTENSIN II-INDUCED HYPERTENSION IS DEPENDENT ON FUNCTIONALLY ACTIVE C-SRCTYROSINE KINASE, BUT NOT FYN: OP 063 (2004) (0)
Abstract P265: Hypertension, Vascular Dysfunction And Downregulation Of The Renin Angiotensin System Sequelae Of COVID-19 (2021) (0)
Abstract MP29: Activation Of Transient Receptor Potential Melastatin 2 (trpm2) Cation Channel Contributes To Nox4-induced Protective Effects In Endothelial Cells. (2020) (0)
Spontaneously Hypertensive Rats (2005) (0)
Abstract P342: Vascular Protein Oxidation and Redox Proteomics in Hypertension (2016) (0)
Reply: Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting System. (2021) (0)
25 Diagnostic Value of Myocardial Blood Flow Imaging in Patients with Ischaemia and Non-Obstructive Coronary Arteries (2023) (0)
Abstract MP13: TRPM7 Downregulation Contributes To Cardiovascular Injury And Hypertension Induced By Aldosterone And Salt (2020) (0)
S-39-3: ENDOTHELIAL INFLAMMATION AND DYSFUNCTION INDUCED BY SARS-COV-2 SPIKE PROTEIN 1 INVOLVE ADAM17 AND INTERFERON ACTIVATION PATHWAYS (2023) (0)
angiotensin peptides in the heart Contribution of circulating renin to local synthesis of (2015) (0)
Essential role of src in angiotensin ii-mediated vascular smooth muscle ca2+ and contractile responses (2000) (0)
Abstract 356: Torcetrapib and Dalcetrapib, CETP inhibitors, Induce Adipocyte-derived Aldosterone and Reactive Oxygen Species Formation (2013) (0)
P-303: In vivo inhibition of ERK1/2-dependent signaling pathways improves vascular function in SHR (2001) (0)
SUPPLEMENTAL DATA Downregulation of Renal TRPM 7 and Increased Inflammation and Fibrosis in Aldosterone-infused Mice : Effects of Magnesium (2008) (0)
Abstract 66: Altered Vascular Reactivity in Mice Overexpressing Adipocyte Mineralocorticoid Receptors - Role of Oxidative Stress and Rho Kinase (2013) (0)
P-633: Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells (2005) (0)
Abstract W P165: Acetaminophen Use and Risk of Stroke and Myocardial Infarction in a Hypertensive Population (2015) (0)
Reply (2021) (0)
Skin-specific mechanisms of body fluid regulation in hypertension. (2023) (0)
Post-COVID-19 illness trajectory: a multisystem investigation. (2021) (0)
Abstract 127: Nox5 Expression In A Vascular Smooth Muscle Cell-specific Manner Induces Fibroblast To Myofibroblast Differentiation (2022) (0)
Abstract 629: Role of Angiotensin-Converting Enzyme 2 in the Regulation Of Resistance Artery Function (2012) (0)
HIGH SODIUM INTAKE INDUCES A CATABOLIC STATE VIA GLOMERULAR HYPERFILTRATION AND ENHANCED GLOMERULOTUBULAR BALANCE IN PATIENTS WITH ESSENTIAL HYPERTENSION (2021) (0)
PP.30.39: HIGH DISCONTINUATION RATE OF ALISKIREN FOLLOWING ANTIBIOTIC THERAPY IN HYPERTENSIVE PATIENTS (2015) (0)
Nox 1 , Nox 4 and Nox 5 , promote vascular permeability and neovascularization in retinopathy (2020) (0)
P-643: Resistance arteries of Ang II-infused osteopetrotic mice show reduced impairment of endothelial function, oxidative stress, and vascular remodeling: Role of inflammation and mCSF in hypertension (2005) (0)
Dr Giacomo Rossitto interviews Professor Rhian Touyz, on the translational applications of vascular smooth muscle cell biology in cardiovascular disease (2018) (0)
Cardiovascular toxicity of tyrosine kinase inhibitors during cancer treatment: Potential involvement of TRPM7 (2023) (0)
Abstract 280: Protein Tyrosine Phosphatase Oxidation and Redox Proteomics in Hypertension (2014) (0)
Running title: Gray et al.; The role of Nox1 in Diabetic Atherosclerosis (2013) (0)
Abstract 264: Serotonin Signaling Through Nox1 in Human Pulmonary Artery Smooth Muscle Cells - Implications in Vascular Remodeling in Pulmonary Arterial Hypertension (2013) (0)
Abstract 029: Nox5 is a Pro-contractile Nox Isoform - Implications in Vascular Contraction and Cardiac Fibrosis (2017) (0)
2010 Annual Fall Conference and Scientific Session of the American Heart Association Council for High Blood Pressure Research in Association With the Council on the Kidney in Cardiovascular Disease (2011) (0)
ROLE OF ALDOSTERONE AND P66SHC PROTEIN ON EXPRESSION OF THE SODIUM-GLUCOSE TRANSPORTER SGLT2 IN THE VASCULAR SYSTEM (2021) (0)
Abstract 052: Rho Kinase and Endoplasmic Reticulum Stress Mediate Peripheral Vascular Dysfunction in a Model of Small Vessel Disease of the Brain (2019) (0)
Abstract P149: VEGF Inhibitor-Induced Hypertension and Renal Injury: Prevention by Aspirin? (2018) (0)
18 MICROPARTICLES INDUCE ENDOTHELIAL CELL SENESCENCE AND CELL CYCLE ARREST THROUGH REDOX-SENSITIVE PROCESSES: IMPLICATIONS IN VASCULAR AGING (2012) (0)
10.13 Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients (2007) (0)
Src-Dependent Erk1/2-Mediated Signaling Pathways and Associated Ang Ii-Stimulated Growth Responses Are Altered in Vascular Smooth Muscle Cells from Arteries of Hypertensive Patients. (2000) (0)
Current Opinion in Nephrology and Hypertension: Editorial introductions (2010) (0)
Abstract 283: Angiotensin II Induces Oxidative Stress Through ADP-ribose-Transient Receptor Potential Melastatin 2-Dependent Mechanisms In Human Microvascular Endothelial Cells: Role Of AT2 Receptor. (2014) (0)
What About Specific Guidelines of Medical Treatment in Patients With Asymptomatic Carotid Stenosis ? (2017) (0)
Reactive Oxygen Species (2019) (0)
MULTI-PARAMETRIC CARDIAC MAGNETIC RESONANCE MARKERS OF ANGIOGENESIS INHIBITOR-INDUCED CARDIOTOXICITY (2020) (0)
Abstract 256: AMP-activated Protein Kinase Activator AICAR Attenuates TNFα-induced Inflammation In Murine Adipocytes. (2014) (0)
CVR-2020-0297 High Sodium Intake, Glomerular Hyperfiltration and Protein Catabolism in Patients with Essential Hypertension (2020) (0)
Angiotensin II induced hyperplasia and hypertrophy in human vascular smooth muscle cells are mediated via AT1 receptors (1998) (0)
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling (2018) (0)
Abstract P094: Crosstalk Between Mas And ET B R Elicits Protective Effects In Endothelial Cells And Vascular Function (2020) (0)
[BP.10.02] NOX4 DEFICIENCY LEADS TO HYPERTENSION AND VASCULAR-RENAL FIBROSIS WITH ENHANCED EFFECTS IN ANG II-DEPENDENT HYPERTENSION (2017) (0)
Clinical Science Editorial 2020 - a year gone by and the year ahead. (2020) (0)
Abstract P383: High Sodium Intake is Independently Associated with Subclinical Hypercortisolism in Hypertensive Patients (2018) (0)
Abstract WP184: Allopurinol Use and Risk of Atrial Fibrillation (2016) (0)
Abstract 350: Downregulation of C-terminal Src Kinase (csk) and Csk-binding Protein (cbp) is Associated With Increased Aldosterone-induced C-src Phosphorylation in Shr Vascular Smooth Muscle Cells (2013) (0)
Abstract P096: Vascular Protein Oxidation and Redox Proteomics in Human Hypertension (2015) (0)
Abstract 074: Vascular Dysfunction in Boys With Androgen Insufficiency - Role of Nox5 and Calcium (2019) (0)
The Renin-Angiotensin System in Cardiovascular and Renal Disease (2012) (0)
Augmented ang II-stimulated vascular growth in human hypertension—role of ERK1/2 mediated c-fos-dependent signaling pathways (2000) (0)
S-12-2: ENHANCING MAS1:ETBR INTERACTION AS A POTENTIAL VASOPROTECTIVE STRATEGY IN STROKE-PRONE SHR (2023) (0)
OR17-05 Hypospadias Is a Predictor of Adverse Cardiometabolic Risk in Adulthood - a Case-Control Study (2020) (0)
Abstract 067: Downregulation Of Vascular Factor-erythroid 2-related Factor-2 And Associated Antioxidant Enzymes In Hypertension (2014) (0)
Hypertension and renal disease prevention before cancer therapy (0)
Abstract 126: Nox5 Regulation of Vascular Contraction Involves Oxidation of Endoplasmic Reticulum Calcium Channels and Calreticulin (2018) (0)
S-45-3: PARP INHIBITION AMELIORATES VEGF INHIBITOR-ASSOCIATED VASCULAR DYSFUNCTION VIA TRPM2 (2023) (0)
A029 Inhibition of mitogen-activated protein kinase attenuates and II-induced alkalinization and contraction in SHR vascular smooth muscle cells (1998) (0)
The role of Nox5 in diabetic complications (2019) (0)
Abstract 490: Redox-Sensitive Osteogenic Factors as Novel Mediators of Vascular Injury in Hypertension (2013) (0)
Abstract 252: Impact of Endothelial Microparticles on Endothelial Cell Signaling and Endothelium-dependent Vasorelaxation (2012) (0)
Abstract P340: Molecular Mechanisms of Fetuin-a-induced Vascular Dysfunction and Inflammation: Role of Oxidative Stress and Toll-like Receptor 4 (2016) (0)
Case of Severe Hypertension and Nephrotic Range Proteinuria. (2018) (0)
182 Syndecan-1 is involved in osteoprotegerin-induced vascular dysfunction (2017) (0)
Abstract 500: Basal Peripheral Arterial Blood Flow Increases Concomitantly with Decreased Cardiopulmonary Reserve and Biomarkers Activation in Patients with Heart Failure and Preserved Ejection Fraction (2013) (0)
Abstract P259: Cardiovascular Pharmacotherapy And Covid-19 (2021) (0)
CARDIOVASCULAR , PULMONARY , AND RENAL PATHOLOGY PTGER 1 Deletion Attenuates Renal Injury in Diabetic Mouse Models (0)

This paper list is powered by the following services:

Other Resources About Rhian Touyz

en.wikipedia.org

What Schools Are Affiliated With Rhian Touyz?

Rhian Touyz is affiliated with the following schools:

Rhian Touyz's Academic­Influence.com Rankings